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                               ABSTRACT 
Introduction: Isolation of the causative microorganisms by using blood 
culture has been the golden standard method for its diagnosis,  the result 
is ready only after 72 hrs after the sampling and during this period, it is 
necessary to treat the suspicious infants for sepsis with antibiotics on the 
basis of the clinical symptoms and the risk factors. Early identification 
of bacterial infections by Quantitative procalcitonin estimation in 
neonatal sepsis cases and appropriate antibiotic therapy will reduce the 
morbidity and mortality. 
Aims and objectives: The aim of the study is to determine the 
diagnostic performance of procalcitonin and C-reactive protein for the 
early diagnosis of Neonatal Septicemia.  
Materials and methods: This cross sectional study was conducted 
in the Institute of Microbiology, Madras Medical College, Rajiv Gandhi 
Government General Hospital (RGGGH), Chennai   in association with 
Neonatal unit Institute of Child Health, Egmore from October 2014 to 
August 2015.Informed consent was obtained from the study population. 
All patients satisfying the inclusion criteria were included in this study. 
Blood collected from each neonate for sepsis work up. Blood culture and 
antibiotic sensitivity pattern were carried out. In this study, the 
estimation of serum C - reactive protein was done by GenX CRP 
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Turbilatex Quantitative method. The measurement of serum 
procalcitonin was done by QDx Instacheck PCT 
Results: In this study, the estimation of serum C-Reactive Protein was 
done by GenX CRP Turbilatex Quantitative method. The sensitivity of 
CRP in detecting sepsis was 62.5% , its specificity was 65.3%, its 
positive predictive value was 35.7% and its negative predictive value 
was 84.4%. The correlation between serum PCT and CRP was   
compared .Higher proportion of the neonates with sepsis had raised PCT 
than those without sepsis. The sensitivity of serum procalcitonin 
(87.5%) for detection of neonatal sepsis was higher than the sensitivity 
of CRP (62.5%). In most of the culture positive cases, the other sepsis 
screening tests were negative , but the level of PCT was elevated.  
Conclusion: Infants who are suspected to have neonatal sepsis 
may lead to unnecessary admission and increased antibiotic 
consumption, a higher incidence of the side effects due to their use, 
increased resistance to the antibiotics, a long hospitalization, the 
separation of the infants from their mothers and increased health costs. 
The  findings of the present study confirm that serum levels of PCT was 
a more reliable marker than the serum levels of CRP and WBC counts in  
the early diagnosis of neonatal sepsis and in the evaluation of the 
response of the disease to the antibiotic therapy. 
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INTRODUCTION 
Invasion of the bloodstream by microorganisms constitutes one of 
the most serious situations in infectious disease. Microorganisms present 
in the circulating blood –whether continuously, intermittently or 
transiently are a threat to every organ in the body 
[1]
. 
Septicemia indicates bacteria are present in the blood, producing 
an infection and reproducing within the blood stream that can have 
serious immediate consequences including shock, multi organ failure, 
Disseminated intravascular coagulation (DIC) and death 
[1]
 . 
Sepsis is the commonest cause of neonatal mortality, it is 
responsible for about 30 – 50% of the total neonatal deaths in 
developing countries 
[2] [23]
. It is estimated that up to 20% of neonates 
develop sepsis and approximately 1% die of sepsis related causes 
[3]
. 
Sepsis related mortality is largely preventable with rational 
antimicrobial therapy and aggressive supportive care  
Neonatal sepsis is a clinical syndrome characterized by signs and 
symptoms of infection with or without accompanying bacteremia in the 
first 30 days of life. It encompasses various systemic infections of the 
newborn such as septicemia, meningitis, pneumonia, arthritis, 
osteomyelitis and urinary tract infections.
 [4]
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Superficial infections like conjunctivitis and oral thrush are not 
usually included under neonatal sepsis.  
The incidence of neonatal sepsis according to the data from 
National Neonatal Perinatal Database (NNPD, 2002-03) is 30 per 1000 
live birth. The NNPD network comprising of 18 tertiary care neonatal 
units across India found sepsis to be one of the commonest causes of 
neonatal mortality contributing to 19% of all neonatal death  
[7]
. 
Microbial colonization of newborn infants begins immediately 
after birth. Infants skin is colonized by flora derived from the body of 
the mother and other depending on the first suitable organism to arrive 
at a particular site as well as factors such as the type of delivery, amount 
of vernix caseosa present at birth, the type of nourishment received 
(breast milk or formula) and the degree of exposure in the hospital 
environment 
[8]
. 
Neonatal sepsis can be divided into two main subtypes depending 
on whether the onset is during the first 72 hours of life ( Early onset 
sepsis ), and after 72 hours of birth ( Late onset sepsis )
 [9] [28]
. 
Early onset septicemia is caused by organisms prevalent in the   
genital tract or in the labour  room and maternity operation theatre. In 
the west early onset infections are mostly caused by group B 
streptococci and Escherichia  coli , while in our setup most cases are 
due to gram negative organisms especially E.coli, Klebsiella, and 
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Enterobacter species. Majority of neonates with Early onset sepsis 
manifest as respiratory distress due to intrauterine pneumonia
[10]
. 
Late onset sepsis is acquired as nosocomical infection from the 
nursery or lying- in ward. In most cases symptoms appear by the end of 
first week or during second week of life. About two third cases of late 
onset septicaemia are caused by Gram negative organisms like 
Klebsiella pneumoniae, Escherichia coli, Pseudomonas aeruginosa  
while the rest are Gram positive organisms including Staphylococcus 
aureus and  Coagulase Negative Staphylococci(CONS).     
Among intramural births (a baby born within premises of the 
centre), Klebsiella pneumoniae was the most frequently isolated 
pathogen (32.5%) followed by Staphylococcus aureus (13.6%). Among 
extramural neonates (referred from community/other hospitals) 
Klebsiella pneumoniae was again the commonest organism (27%) 
followed by Staphylococcus  aureus  (15%) and Pseudomonas (13%)
[8]
. 
Isolation of the causative microorganisms by using blood culture 
has been the golden standard method for its diagnosis, the result is ready 
only after 72 hrs after the sampling and during this period, it is 
necessary to treat the suspicious infants for sepsis with antibiotics on the 
basis of the clinical symptoms and the risk factors.  
Infants who are suspected to have neonatal sepsis may lead to 
unnecessary admission and increased antibiotic consumption, a higher 
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incidence of the side effects due to their use, increased resistance to the 
antibiotics, a long hospitalization, the separation of the infants from 
their mothers and increased health costs.   
An inflammatory marker such as C Reactive Protein (CRP) does 
not reliably differentiate between the systemic inflammatory response 
and sepsis. Procalcitonin (PCT), a  precursor of calcitonin is a 116 
amino acid protein secreted by the C cells of thyroid gland in normal 
situation but its levels may increase during septicemia, meningitis, 
pneumonia and urinary tract infection
[11]
. 
Early identification of bacterial infections by Quantitative 
procalcitonin estimation in neonatal sepsis cases and appropriate 
antibiotic therapy will reduce the morbidity and mortality.  
This study was done to determine the various bacterial agents 
involved in neonatal sepsis cases and to identify the risk factors and to 
determine the antimicrobial susceptibility pattern. To compare the 
diagnostic performance of C- Reactive protein and procalcitonin with 
the gold standard culture method.  
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AIMS AND OBJECTIVES 
 To isolate and identify the bacteria involved  in Neonatal sepsis  
 To study the antibacterial   susceptibility pattern for the isolates.  
 To know the risk factors involved in neonatal sepsis.  
 To study the prevalence of neonatal sepsis cases.  
 To determine the diagnostic performance of procalcitonin and  
C-reactive protein for the early diagnosis of Neonatal Septicemia.  
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REVIEW OF LITERTURE 
DEFINITION 
Neonatal sepsis or septicemia is the term that have been used to 
describe the systemic response to infection in newborn infants during 
the first 28 days of life 
[3]
. 
Neonatal sepsis is a clinical syndrome characterized by signs and 
symptoms of infection with or without accompanying bacteremia in the 
first 30 days of life 
[12]
. 
EPIDEMIOLOGY OF NEONATAL SEPSIS: 
The incidence of neonatal sepsis according to the data from 
National Neonatal Perinatal Database (NNPD, 2002-03) is 30 per 1000 
live birth.  The NNPD network comprising of 18 tertiary care neonatal 
units across India found sepsis to be one of the commonest causes of 
neonatal mortality contributing to 19% of all neonatal death  
[7]
.  
The incidence of sepsis varies from 7.1 to 38
[13]
 per 1000 live 
births in asia. 6.5 to 23
[14]
/1000 live  births in Africa, 3.5 
[15]
to8.9
[16]
 per  
1000 live birth in south America and carribeans:   6
[14]
 per 1000 live 
births in USA and Australia 
COLONIZATION OF ORGANISMS CAUSING NEONATAL 
INFECTION: 
The fetus normally encounters no organisms during development 
and the newborn infant become harmlessly colonized by bacteria 
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acquired from the birth canal and the environment. This is because of 
the barrier to infection provided by the placenta and membranes, the low  
pathogenicity of  of colonizing microorganisms and the rela tive 
competence of the babies defence mechanisms. It is usually when one or 
other of these factors is altered that fetal or neonatal infection occurs.  
Colonization of healthy infants: 
The nature of colonizing organisms is determined by the pattern 
of flora in the birth canal and in the environment. Babies born at home 
are colonized by organisms, derived primarily from the mother .These 
organisms and those acquired from family members, tend to be 
community derived antibiotic sensitive organisms, of limited 
pathogenicity. 
In the postnatal ward, the baby acquire organisms from the ward 
environment, other babies and the clinical staff.  
Colonization of the intestinal tract: 
The predominant organisms acquired from normal babies are 
members of the family Enterobacteriaceae( incuding E.coli, Klebsiella 
spp, and Citrobacter spp).  
Colonization of the respiratory tract: 
Colonization of the upper respiratory tract occurs rapidly and 90% 
of infants have positive pharyngeal cultures by the third day. Coagulase 
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negative staphylococci are the commonest, followed by Streptococcus 
viridians and staphylococcus aureus. 
Colonization of the skin: 
Skin colonization is very quick, with the number of bacteria 
increasing 100 fold during the first week. Coagulase negative 
staphylococci predominate but Staphylococcus aureus may be found in 
65% of infants. A host of other organisms can be found, including yeasts 
and a range of saprophytic bacteria. The umbilicus and perineum and 
axilla are the most heavily colonized
[90-91]
. 
Colonization of the infants on a Neonatal Intensive Care Units (NICU) 
These babies are at greatest risk of becoming colonized by the 
pathogens, which often show resistance to antibiotics. The pattern of 
bowel colonization is very different among sick preterm infants. CONS 
and antibiotic resistant gram negative organism are the predominate 
organisms
[17] [18]
 
Skin colonization on the NICU is mainly the CONS, which can be 
isolated from over 90% of all positive culture. Staphlococcus 
epidermidis accounts for 80% and Staphylococus haemolyticus for 
almost all of the remainder
[19]
. 
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Balance between colonization and infection: 
 Most babies become colonized without becoming infected , but in 
others various host factors or the pathogenicity of the organisms 
result in tissue invasion and sepsis. 
 Intact skin and mucous membranes present an important barrier to 
microorganisms. Abrasions and cuts, mucosal injury,  cannulae, 
catheter and endotracheal tubes all open the way for bacterial 
invasion. 
 Certain infective agents have an inherent  ability to penetrate the 
placental barrier, often damaging the placenta. Ascent of the 
vaginal organisms into the uterine cavity prior to rupture of 
membranes is rare. Once the membranes rupture, the risk 
increases progressively with time. 
 Vaginal delivery inevitably results in contamination and the 
beginning of colonization of the skin and gut of the baby. Vaginal 
flora varies considerably from woman to woman and many cases 
of Early onset sepsis result from the vaginal carriage of 
opportunistic pathogens. 
 In addition to the organism acquired during birth all babies are 
subject to further microbiological contamination from the 
environment. People are the main source of such contamination.  
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 Babies are less able to combat infection than the older children. 
This is further compromised by prematurity. 
 Competition between bacteria is a controlling influence on the 
level of colonization and risk of infection. There is competitive 
inhibition of gram negative organisms by Lactobacillus bifidus in 
the gut of the breast –fed infants [20]. 
 The various risk factors involved in neonatal sepsis are LBW [21], 
PROM 
[22]
, difficult delivery and instrumentation, birth asphyxia, 
difficult resuscitation 
[23]
, ventilator therapy
[24]
, intravenous 
catheterization
[23]
 and administration of parenteral nutrition
[25]
. 
PATHOGENESIS OF SEPSIS 
Infection begins when microorganisms circumvent or penetrate 
host barriers such as skin and mucosa . Depending on the infecting 
agents , virulence and      immuno competence of the patients, local hos t 
defences may be overwhelmed , resulting in invasion of the 
bloodstream.       
The physiologic manifestations of the inflammatory response are 
mediated by a variety of pro inflammatory cytokines, principally 
Tumour necrosis factor (TNF), Interleukin -1 (IL-1) and IL-6 and by 
products of activation of the complement and coagulation systems. 
Elevated levels of IL-6, TNF and Platelet activating factor have been 
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reported in new born infants with neonatal sepsis. IL-6 is the cytokine 
most often elevated in neonatal sepsis. 
Toxic products released by the microbes in the circulation activate 
systemic host defences, including plasma factors ( complement and 
clotting cascades) and cellular components( neutrophils, monocytes, 
macrophages and endothelial cells). In turn, activated cells produce 
potentially toxic mediators that augment the inflammatory response. 
This escalating immune response in concert with microbial toxins can 
lead to shock, multiple organ failure ,death.
 [26]
 
A predominance of male infants apparent in almost all studies of 
sepsis in the new born but not among infants in utero. The usual male 
predominance in neonatal sepsis has suggested the possibility of a sex 
linked factor in host susceptibility. A gene located on the X 
chromosome and involved with function of the thymus or with synthesis 
of immunoglobulins has been postulated. The female has double the 
number of genes affecting these factors and thus might possess a greater 
resistance to infection. 
 12 
PATHOGENESIS OF SEPSIS 
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ETIOLOGICAL AGENTS 
GRAM POSITIVE ORGANISMS 
Staphylococcus aureus 
Staphylococcus epidermidis. 
Streptococcus agalactiae
[22]
 
Listeria monocytogenes
[27]
 
 Through the years, there has been a shift in the microorganisms 
responsible for neonatal Septicaemia.  
 During the 1930’s Group A Streptococcus were the predominant 
organisms. 
 In  the 1950s the phase group I Staphylococcus aureus was the 
most common bacterial agent causing septicaemia in neonatal 
units. More recently, coagulase positive Staphlyococcus disease in 
nurseries has been caused by organisms of the phase II group. The 
incidence of CONS sepsis is high in neonatal intensive care 
units
[9][105-106]
. 
 Methicillin –resistant organisms are an increasing problem in 
NICU neonates and require treatment with vancomycin . MRSA  
can spread within NICU in epidemic and endemic fashion. 
Infection control measures including identification of colonized 
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infants by routine surveillance and cohorting and isolation of 
colonized infants may be required to prevent spread and 
persistence of the organisms
[18]
. 
 The Group B Streptococcus is the most common Gram positive 
organism causing septicaemia during the first month of life. 
Vertical transmissions from mother to infants are the most 
common route of infection. The incidence of Group B 
streptococcal disease has varied widely from place to place and 
from year to year. Group A Streptococcal disease is not as 
common now as in previous decades. Group D Streptococci 
include the Enterococci and several particularly S.bovis, which 
have been found in neonatal infection.  
 Coagulase Negative Staphylococci may be identified in blood 
cultures of babies and are frequently dismissed as contaminants. 
Repeated isolation of the organism from blood associated with 
clinical signs of septicaemia should alert the physician to its 
pathogenic role Coagulase negative Staphylococci are frequently, 
but not always associated with arterial or venous catheters or 
ventriculo peritoneal shunts. Eradication of infection requires 
removal of the catheter or prosthesis as well as appropriate  
antibiotic therapy
[13] [18]
. 
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GRAM NEGATIVE ORGANISMS 
Klebsiella pneumoniae. 
Escherichia coli. 
Pseudomonas aeruginosa. 
Haemophilus influenza. 
Acinetobacter spp. 
Enterobacter aerogenes
[28]
 
Sepsis with the gram negative organisms increasing now a days 
particularly in the asian countries
[29] [30]
 
 From the late 1950’s onwards E. Coli has been an important cause 
of neonatal sepsis. Finally Klebsiella have been relatively recent 
pathogen,   accounting for a high proportion of anitibiotic- 
resistant organisms that colonize and infect babies in neonatal 
intensive care units
[5]
 . The inadvertent use of broad spectrum 
antibiotics has led to the emergence of multidrug resistant gram 
negative bacteria
[31]. 
Klebsiella species are of importance in this 
regard.
 [32]
 
 The prevalence rates for a specific bacterial pathogen vary from 
nursery to nursery and may change abruptly in any one unit.  
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 The number of nosocomial infections has increased dramatically 
in the past decade but pathogenic E.coli, Klebsiella, Enterobacter 
and Pseudomonas organisms have been responsible for majority 
of the gram negative infections. GNB causes more than 50% of 
hospital acquired infections. Most studies have assumed that GNB 
are part of the transient flora only and easily removed by hygienic 
hand washing with soap and water
[33]
. 
 E. coli are the most common gram negative bacteria causing 
septicaemia during the neonatal period. Approximately 40% of E. 
Coli strains causing septicaemia possess K 1 capsular antigen 
[34]
 
and strains identical with that in blood can usually be identified in 
the patient’s nasopharynx or rectal cultures [35]. K1 strains in the 
blood or cerebrospinal fluid of most infants with meningitis 
related to E. coli. These strains were also cultured from the blood 
of some infants and adults with sepsis but without meningitis.  
 Pseudomonas aeruginosa is usually a cause of late onset disease 
in infants who are presumably infected from their gut flora or 
from equipment, aqueous solutions ,or on occasion, the hands of 
health care personnel
[34]
. 
 The neonates who receives broad spectrum antibiotics while in an 
environment potentially contaminated by “water-bugs: 
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(respirators, moist oxygen) is likely to develop disease caused by 
Pseudomonas species.
 [34]
 
 Among the Enterobacter species Enterobacter aerogens, E. 
cloacae, E. sakazakii and E.bormaechei have caused sepsis and a 
severe form of necrotizing meningitis in neonates. Contaminated 
infant formula has been identified as a source of infection. 
Parenteral nutrition  and bladder catheterization are identified as 
risk factors. 
 Citrobacter is an occasional inhabitant of GIT and are responsible 
for disease in neonates and immunocompromised patients. It 
causes sporadic and epidemic neonatal sepsis and meningitis
[14]
. 
 Acinetobacter species is an important emerging nosocomical 
pathogen in neonatal septicemia.
[36] [37]
Septicaemia due to 
Acinetobacter spp are common in babies with predisposing factors 
like endotracheal intubation.
 [29]
  
 Neisseria meningitides, Haemophilus influenza  and Sretptococcus 
pneumoniae are relatively uncommon in neonates. S.pneumoniae 
cause early onset sepsis that mimic neonatal disease caused by 
groupB. Streptococci. Most people exposed to Listeria 
monocytogenes do not develop illness, but the pregnant women 
may suffer pregnancy loss and the neonate may develop sepsis 
and meningitis. 
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 Inhalation of infected amniotic fluid may produce pneumonia and 
sepsis in utero, manifested by fetal distress or neonatal asphyxia. 
Exposure to pathogens at delivery and in the nursery or 
community is the mechanism of infection after birth.   
MULTIDRUG RESISTANT GRAM NEGATIVE BACTERIA 
 In septicemic neonates, positivity of blood culture exhibits 
predominantly multidrug resistant gram negative rods among the 
isolates.
 [20]
 
 Multi drug resistant gram negative bacteria are associated with 
production of Extended Spectrum Beta Lactamase(ESBL).As 
these enzymes are active against narrow spectrum cephalosporins, 
Extended spectrum cephalosporins, aztreonam, the treatment 
becomes more problematic.
 [38]
 
 Several outbreaks of infection caused by Klebsiella isolates that 
are simultaneously resistant to broad spectrum beta lactam 
antibiotics
 [39]
. Studies carried out in various parts of India have 
reported prevalence of ESBL producing Klebsiella isolates.
 [40]
 
 Jain et al observed ESBL production in 87.2% isolates of 
Klebsiella species, 65.3% isolates of Escherichia coli and 33.3% 
isolates of Pseudomonas aeruginosa.
 [41]               
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CLASSIFICATION OF NEONATAL SEPSIS
[6] [12]
: 
Neonatal sepsis can be classified into  two major categories 
depending up on the onset of symptoms. 
1.Early onset of sepsis (EOS) presents within the first 72 hours 
of life. In severe cases, the neonate may be symptomatic at birth. Infants 
with EOS usually present with respiratory distress and pneumonia. The 
source of infection is generally the maternal genital tract.  
RISK FACTORS FOR EOS 
Some material / perinatal conditions have been associated with an 
increased risk of EOS. Knowledge about these potential risk factors 
would help in early diagnosis of sepsis. Based on the studies from India, 
the following risk factors seem to be associated with an increased risk of 
early onset sepsis
[10]
. 
 Low  birth weight (<2500gms) or prematurity 
 Febrile illness  in the mother with evidence of bacterial infection 
within 2 weeks prior to delivery 
 Foul smelling and /or meconium stained liquor 
 Rupture of membranes >24 hrs 
 Prolonged labor(sum of 1st and 2nd stage of labour ≥ 24 hrs)  
 Perinatal asphyxia(Apgar slore <4at 1 minute)  
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Presence of foul smelling liquor or three of the mentioned risk 
factors warrant initiation of antibiotic treatment. Infants with two risk 
factors should be investigated and then treated accordingly.  
2. Late onset sepsis (LOS) presents after 72hours of  age. The 
source of infection in LOS is either  nosocomial  (hospital acquired) or 
community acquired and neonates usually present with septicaemia, 
pneumonia or meningitis
[42]
.  
RISK FACTORS FOR LOS 
Various factors that predispose to an increased risk of nosocomial 
sepsis include 
 Low birth weight 
 Prematurity 
 Admission in intensive care unit 
 Mechanical ventilation 
 Invasive  procedures, administration of parenteral fluids, and use 
of stock solutions.  
 Risk of community- acquired Late onset sepsis 
 Poor hygiene 
 Poor cord care 
 Bottle feeding, and pre lacteal feeds. 
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Breastfeeding helps in prevention of infections. LOS is a frequent 
and important problem among VLBW preterm infants.  
Successful strategies to decrease Late onset sepsis should 
decrease Very Low Birth Weight mortality rates, shorten hospital stay 
and reduce costs
[43]
. 
CLINICAL FEATURES 
Nonspecific Features 
The earlier signs of sepsis are often subtle and nonspecific; indeed 
a high index of suspicion is needed for early diagnosis. Neonates with 
sepsis may present with one or more of the following symptoms and 
signs such as 
 Hypothermia or fever, 
 Lethargy, 
 Poor cry 
 Refusal to suck, 
 Poor perfusion, prolonged capillary refill time,  
 Hypotonia , absent neonatal reflexes,  
 Brady / Tachycardia , 
 Respiratory distress, 
 Apnea and gasping respiration. 
 Hypo/ Hyperglycemia and Metabolic acidosis. 
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OTHER SYSTEMS INVOLVEMENT  
 Central Nervous System (CNS) 
 Bulging anterior fontanelle, 
 Vacant stare, 
 High-pitched cry, excess irritability,  
 Stupor/coma, seizures, neck retraction.  
 Presence of these features should raise a clinical suspicion of 
meningitis 
Cardiac System  
 Hypotension, poor perfusion, shock  
Gastrointestinal System  
 Feed intolerance.  
 Vomiting, diarrhea. 
 Abdominal distension. 
 Paralytic ileus 
 Neonatal necrotizing enterocolitis (NNEC) [87]  
Hepatic System 
 Hepatomegaly, 
 direct hyperbilirubinemia (especially with urinary tract infections)  
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Renal System 
 Acute renal failure  
Hematological 
 Bleeding, petechiae, purpura  
Skin Changes 
 Multiple pustules, abscess, sclerema, mottling, umbilical 
redness and discharge.   
INVESTIGATIONS 
Since treatment should be initiated in a neonate suspected to have 
sepsis without any delay, only minimal and rapid investigations should 
be undertaken 
[14]
 
Blood Culture:  Blood culture is the gold standard for diagnosis 
of septicaemia and should be performed in all cases of suspected sepsis 
prior to starting antibiotics. It is not safe to take large samples of blood 
from children. A positive blood culture with sensitivity of the isolated 
organism is the best guide to antimicrobial therapy. Therefore it is very 
important to follow the proper procedure for collecting a blood culture.  
The optimal volume of blood required for successful identification of 
organism from infants and children has not been clearly delineated
 [1]
.       
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Baron EJ et al., stated that recommendations for blood volumes 
for cultures from infants and children, only 1-5 ml of blood should be 
drawn for bacterial culture. 
A positive blood culture with sensitivity of the isolated organism 
is the best guide to antimicrobial therapy. Therefore it is very important 
to follow the proper procedure for collecting a blood culture.  
It is now possible to detect bacterial growth within 12-24 hours by 
using improved bacteriological techniques such as BACTEC and 
BACT/ALERT blood culture systems. These advanced techniques can 
detect bacteria at a concentration of 1-2 colony-forming unit (cfu) per 
mL.  
Septic Screen 
All neonates suspected to have sepsis should have a septic screen 
to corroborate the diagnosis
 [6] [10]
. However, the decision to start 
antibiotics need not be conditional to the sepsis screen result, if there is 
a strong clinical suspicion of sepsis. The various components of the 
septic screen include 
1) Total leukocyte count (TLC) 
2) Absolute Neutrophil count (ANC) 
3) Immature to total (IT) neutrophil ratio 
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4) Micro-erythrocyte sedimentation rate  
5) C -reactive protein (CRP) :  
 The ANC varies considerably in the immediate neonatal period[42]. 
 The lower limit for normal ANC begins at 1800/cmm at birth, 
rises to 7200/cmm at 12 hours of age and then declines and 
persists at 1800/cmm after 72 hours of life.  
 The I/T ratio is lesser than or equal to 0.16 at birth and 
declines to a peak value of 0.12 after 72 hours of age  
 Presence of two abnormal parameters in a screen is associated 
with a sensitivity of 93-100%, specificity of 83%, positive and 
negative predictive values of 27% and 100% respectively in 
detecting sepsis. Hence, if two (or more) parameters are 
abnormal, it should be considered as a positive screen and the 
neonate should be started on antibiotics. 
 If the screen is negative but clinical suspicion persists, it 
should be repeated within 12 hours. If the screen is still 
negative, sepsis can be excluded with reasonable certainty.  
Lumbar puncture (LP)  
 The incidence of meningitis in neonatal sepsis has varied from 
0.3-3% in various studies
[4][9]
. The clinical features of septicemia 
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and meningitis often overlap; it is quite possible to have 
meningitis along with septicemia without any specific 
symptomatology.  In Early Onset Sepsis, lumbar puncture is 
indicated in the presence of a positive blood culture or if the 
clinical picture is consistent with septicaemia.  
 It is not indicated if antibiotics have been started solely due to the 
presence of risk factors. In situations of late onset sepsis, LP 
should be done in all infants prior to starting antibiotics.  
 Lumbar puncture could be postponed in a critically sick neonate. 
It should be performed once the clinical condition stabilizes. The 
cerebrospinal fluid characteristics are unique in the newborn 
period . 
     RADIOLOGY 
 Chest x-ray should be considered in the presence of respiratory 
distress or apnea. 
 An abdominal x-ray is indicated in the presence of abdominal 
signs suggestive of Necrotizing Enterocolitis (NEC)  
 Neurosonogram and computed tomography (CT scan) should be 
performed in all patients diagnosed to have meningitis.  
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URINE CULTURE  
 Urine cultures have a low yield and are not indicated routinely. 
However, neonates at risk for fungal sepsis, with urogenital 
malformation or vesicoureteral reflex or suspected of UTI (crying 
during micturition) should have a urine examination done to 
exclude urinary tract infection (UTI).  
 Urine cultures obtained by suprapubic puncture, bladder 
catheterization or clean catch sample from midstream of urine  
 UTI may be diagnosed in the presence of one of the following:   
 >10 WBC/mm3 in a 10 mL centrifuged sample 
 >104 organisms/mL in urine obtained by catheterization and  
 any organism in urine obtained by suprapubic aspiration  
ACUTE PHASE PROTEINS  
C-REACTIVE PROTEIN 
C-reactive protein is a nonspecific acute phase protein that rises 
in response to infectious and noninfectious inflammatory processes. It is 
synthesized by hepatocytes. Good evidence exists to support the use of 
CRP measurement along with other established  diagnostic tests (Blood 
culture,WBC count and Differential count ) to establish or exclude the 
diagnosis of sepsis in full term or near term infants.  
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The three clinical laboratory methods namely 
1) Qualitative test 
2) Semi-quantitative test  
3) Quantitative test are carried out to measure serum  CRP levels.  
 The quantitative immunoassay is the most rapid sophisticated 
sensitive method of detecting and measuring CRP. Accurate 
measurement of CRP can be made by laser nephelometry or 
single radio immuno diffusion assay
[44]
. 
 Increased CRP levels can occur in infants for upto three days 
of life from non-infectious causes. Maternal fever, PROM, 
Fetal distress, Pneumothorax and Meconium aspiration 
pneumonitis could cause elevated CRP levels. 
 The CRP levels do not always rise above 10mg/ l  in preterm 
infants or those infants with overwhelming sepsis, resulting in 
a false negative test results
[51][52]
. 
 In a study done by Khassawneh et al., [53] (2007), it was 
concluded that CRP ,IL-6 and IgM are useful in the diagnosis 
of gram negative neonatal sepsis and CRP continues to be the 
best single test. According to them a CRP value 5 mg/L was 
the best among the three parameters with 95% sensitivity.           
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 According to Philip A and Andrews P [54](1986) the semi 
quantitative latex agglutination assay involves the use of serial 
dilution of serum with saline. 
 As per Murex [55] (1995) diagnostics, Murex CRO the 
qualitative latex agglutination test can be performed rapidly at 
the bedside within 10 to 15 minutes. CRP is a useful serum 
marker to assess and monitor the presence, severity and course 
of the  inflammatory response in infectious and non-infectious  
disorders including acute myocardial infarction, angina, 
malignancies, burns and trauma as reported by Jaye D and 
Waites K 
[56] 
(1997). 
PROCALCITONIN:  
Procalcitonin is a 116 aminoacid peptide that has an approximate 
MW of 14.5 KDa and belongs to the calcitonin super family of peptides.  
 Its level increases significantly in severe systemic infections, as 
compared to other parameters of microbial infection. 
 The short half –life (25-30 hours in plasma) of PCT, coupled with 
its virtual absence in health and specifically for bacterial 
infections, gives it a clear advantage over the other markers of 
bacterial infection. 
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 Studies have also shown that an increase in PCT levels is minimal 
in viral infections while levels increase rapidly after a single 
injection with endotoxin. Increased PCT levels comparable to 
what is observed in severe sepsis were also seen in Addisonian 
crisis, transplant patients receiving T-cells antibody therapy
[45]
. 
 PCT is physiologically elevated during first 3 days of life. But it 
has been found to be a reliable marker of LOS in newborn babies 
with a sensitivity and specificity of nearly 100%. Comparative 
studies have shown that PCT is a more reliable marker of sepsis 
compared to CRP. 
 Quantitative measurement of PCT is performed by 
immnuoluminometric assay (ILMA) with two monoclonal 
antibodies. After the initial surge of PCT during first 3 days of 
life, the mean normal serum PCT is around 0.5 ng/ml
[46]
. 
 Procalcitonin is a biomarker that exhibits greater specificity than 
other pro inflammatory marker (e.g Cytokines) in identifying 
patients with sepsis and can be used in the diagnosis of bacterial 
infection. 
 Resch et al[48] (2003)have documented that the reliability of 
Procalcitonin determination in the diagnosis of early onset 
neonatal sepsis as compared to CRP and IL-6 revealed sensitivity 
of PCT as 77% compared to 54% and 69% for IL-6 and CRP.  
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 Carrigan et al.,[49] (2004) reported that the broth culture method is 
the gold standard for the diagnosis of bacterial infection but a 
definitive result can take 24 hrs or more before a conclusive 
diagnosis. Procalcitonin owing its specificity to bacterial infection 
has been proposed as a pertinent marker in the rapid diagnosis of 
bacterial infections. Multivariate logistic regression identified that 
a PCT=2.6 ng / ml was independently associated with the 
development of sepsis shock. 
 Simon et al., [50](2004) have stated that Procalcitonin level 
increases significantly in severe systemic infections as compared 
to other parameters of microbial infection.  
The incidence of meningitis in neonatal sepsis has varied from 
0.3-3% in various studies. Lumbar puncture is indicated in the presence 
of a positive blood culture or if the clinical picture is consistent with 
septicemia. 
In early onset sepsis, urine cultures have a low yield and are not 
indicated. Urine cultures obtained by suprapubic puncture or bladder 
catheterization have been recommended in all cases of LOS. 
Adequate and proper supportive care is crucial in a sick neonate 
with sepsis. He/ she should be nursed in a thermo-neutral environment 
taking care to avoid hypo/hyperthermia. Oxygen saturation should be 
maintained in the normal range; mechanical ventilation may have to be 
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initiated if necessary. If the infant is hemo dynamically unstable, 
intravenous fluids should be administered and the infant is to be 
monitored for hypo/hyperthermia. There cannot be a single 
recommendation for the antibiotic regimen of neonatal sepsis for all 
settings. 
The choice of antibiotics depends on the prevailing flora in the 
given unit and their antimicrobial sensitivity. Decision to start 
antibiotics is based upon the clinical features and / or a positive septic 
screen. However duration of antibiotic therapy is dependent upon the 
presence of a positive blood culture and meningitis.  
Aggressive management of suspected maternal chorioamnionitis 
with antibiotic therapy during labor along with rapid delivery of the 
infant reduces the risk of early- onset neonatal sepsis.  Vertical 
transmission of Group B Streptococcal sepsis is significantly reduced by 
selective intrapartum chemoprophylaxis.  
Principles for the prevention of nosocomial infection include 
adherence to universal precautions with all patient contact, avoiding 
nursery crowding, strict compliance with hand washing , meticulous 
neonatal skin care, minimizing the risk of catheter contamination, 
decreasing the number of veni-punctures and mechanical ventilation 
days and providing education and feedback to nursery personnel. 
Management  
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SUPPORTIVE 
 Adequate and proper supportive care is crucial in a sick neonate 
with sepsis. He/she should be nursed in a thermo-neutral 
environment taking care to avoid hypo/hyperthermia 
 Oxygen saturation should be maintained in the normal range; 
mechanical ventilation may have to be initiated if necessary.  
 If the infant is hemodynamically unstable, intravenous fluids 
should be administered and the infant is to be monitored for 
hypo/hyperglycemia. Volume expansion with crystalloids/colloids 
and judicious use of inotropes are essential to maintain normal 
tissue perfusion and blood pressure.  
 Packed red cells and fresh frozen plasma might have to be used in 
the event of anemia or bleeding diathesis.  
ANTIMICROBIAL THERAPY 
Indications for starting antibiotics: The indications for starting 
antibiotics in neonates at risk of EOS include any one of the following:  
a. Presence of >3 risk factors for early onset sepsis (see above)  
b. Presence of foul smelling liquor  
c. Presence of more than 2 antenatal risk factor(s) and a positive septic 
screen and  
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d. Strong clinical suspicion of sepsis.  
The indications for starting antibiotics in LOS include:  
a. Positive septic screen and/or  
b. Strong clinical suspicion of sepsis.  
 CHOICE OF ANTIBIOTICS  
Empirical antibiotic therapy should be unit-specific and 
determined by the prevalent spectrum of etiological agents and their 
antibiotic sensitivity pattern. Antibiotics once started should be 
modified according to the sensitivity reports. 
1) The choice of antibiotics depends on the prevailing flora in the 
given unit and their antimicrobial sensitivity.  Decision to start 
antibiotics is based upon clinical features and/ or a positive septic 
screen. However duration of antibiotic therapy is dependent upon 
the presence of a positive blood culture and meningitis.   
2) For infections that are likely to be community-acquired where 
resistant strains are unlikely, a combination of ampicillin or 
penicillin with gentamicin may be a good choice as a first line 
therapy.  
3) For infections that are acquired during hospital stay, resistant 
pathogens are likely and a combination of ampicillin or 
cloxacillin with gentamicin or amikacin may be instituted. In 
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nurseries where this combination is ineffective due to the 
presence of multiple resistant strains of klebsiella and other gram-
negative bacilli, a combination of a third generation cephalosporin 
(cefotaxime or ceftazidime) with amikacin may be 
appropriate
[58][59]
. 
4) For sepsis due to enterococcus, a combination of ampicillin and 
gentamicin is a good choice for initial therapy. Vancomycin 
should be used for the treatment of enterococcus resistant to the 
first line of therapy. 
 Gladstone et al., [57] (1990) documented the introduction of 
aminoglycoside antibiotics- Kanamycin in the early 1960s and 
later Gentamycin  provides vastly improved therapy for 
bacteremia due to Gram negative organisms, the leading cause of 
sepsis at that time. 
 Benzyl Penicillin is most suitable for the treatment of infections 
due to Group B Streptococci. 
 Septicemia due to Pseudomonas aeruginosa is best managed by 
ceftazidime. 
 Betalactamase resistant penicillins and vancomycin are indicated 
in the treatment of infection caused by Staphylococcus aureus.  
 Ampicillin is the drug of choice for Listeriosis.  
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 A combination of amikacin and cefotaxime is ideal for treatment 
of neonatal meningitis (Meharbansingh 2010).  
PROGNOSIS 
The reported mortality rate in neonatal sepsis from various study 
in India between 10 to 15 % .Early institution of specific antibiotic 
therapy with the aid of blood culture with sepsis screen excellent 
supportive care close monitoring of vital signs and judicious use of fresh 
blood , fresh frozen plasma and immunotherapy is slightly to improve 
the outcome of the neonates with septicemia
[60] 
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MATERIALS AND METHODS 
Study Place: This study was conducted in the Institute of 
Microbiology, Madras Medical College, Rajiv Gandhi Government 
General Hospital (RGGGH), Chennai   in association with Neonatal unit 
Institute of Child Health, Egmore. Informed consent was obtained from 
the study population. All patients satisfying the inclusion criteria were 
included in this study. 
Study Design: Cross sectional study  
Study Period: October 2014 to August 2015 
Study Group: A total of 100 clinically suspected cases of 
newborns admitted in newborn ward with symptoms and signs 
suggestive of sepsis were taken for the study.  
ETHICS CONSIDEATION 
This study was approved by the institutional scientific and ethical 
committee and written informed consents were obtained from the 
parents. Neonatal history was taken from the parents by structured 
questionnaire. 
INCLUSION CRITERIA 
The clinical criteria taken as indicative of sepsis were:  
1) Maternal risk factor such as fever, PROM >24hrs  
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2) Neonatal history: Low birth weight (<2500gm), premature birth 
(<37 weeks) 
3) Signs and symptoms of sepsis: Feeding intolerance, lethargy, 
temperature instability, apnea, respiratory distress poor perfusion, 
seizures, tachypnea, bradycardia, abdominal distension or 
vomiting. 
Neonates who had any features mentioned from I and II associated 
with two or more clinical symptoms of sepsis would warrant a septic 
screen. 
According to clinical symptoms of sepsis, microbiologic and 
laboratory results(C Reactive Protein, white cell count, plate let count 
and blood culture), neonates classified into three groups.  
 Proven sepsis: Positive blood culture and clinical symptoms of 
sepsis. 
 Suspected sepsis: Negative blood culture with abnormal 
laboratory results. 
 Clinical sepsis: Negative blood culture and normal laboratory results. 
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EXCLUSION CRITERIA 
 Newborns who were started antibiotics or those who developed 
the signs of sepsis within 72hours of discontinuation of 
antibiotics. 
 Birth asphyxia, aspiration syndromes 
 Inborn errors of metabolism 
 Congenital anomalies  
SAMPLE COLLECTION  
Under strict aseptic precautions, venepuncture site was cleaned 
with 70% alcohol and then with 2 % Povidone Iodine 
[61]
. The 
disinfectant was allowed to act for 1 minute and then 1-2ml of blood 
sample was collected with a sterile syringe and added into a sterile crew 
capped blood culture bottle containing 10 ml of sterile Brain Heart 
Infusion broth(BHI broth) at the bed side was labelled with name, age 
,sex, IP No, date and time of collection and culture bottles transported 
immediately to the laboratory.  
Using a sterile syringe and needle, withdraw about 1-2 ml for 
blood culture, another 1-2 ml for measurements of procalcitonin, c-
reactive protein. 
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Serum was separated from blood cells by centrifugation and 
stored in 2 plastic tubes at -20  C for measurements of PCT and CRP. 
SAMPLE PROCESSING 
The culture bottle were incubated at 37  C for 24-48 hours 
.Inspection and subculture was done  during the first day and examined 
for turbidity, pellicle formation and deposits, the subcul tures made onto 
the following plates  using sterile techniques 
[ 62]
. 
 MacConkey Agar plate 
 5%Sheep Blood Agar plate 
 Chocolate Agar plate 
INTERPRETATION 
All plates were checked for growth in culture plates after 24-48 
hours The colony size, shape, edge, margin and consistency was noted. 
IDENTIFICATION 
Gram’s staining was performed from growth obtained [1]. 
In case of Gram Positive cocci, the following tests were 
performed; 
 Catalase, 
 Slide coagulase, 
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 Tube coagulase, 
 Novobiocin sensitivity, 
 Optochin sensitivity, 
 Bile esculin hydrolysis, 
 Heat test. 
ANTIBIOTIC SUSCEPTIBILITY TESTS 
Antibiotic susceptibility testing of the bacterial isolates were 
performed by Kirby Bauer’s disk diffusion method on Mueller -Hinton 
agar and zone diameter were interpreted according to CLSI 
guidelines
[63]
. 
Medium Used: MHA (Mueller Hinton agar plate)  
Inoculum: 0.5 McFarland turbidity (lawn culture)   
Incubation: 37  C Ambient air, incubated for 16-18 hours 
PREPARATION OF INOCULUM FOR SENSITIVITY 
TESTING 
About 4-5 colonies of similar morphology were picked up with 
the help of straight wire and inoculated in 5ml of suitable broth, and it is 
incubated for 3-5hrs which gives 0.5  McFarland turbidity.  A sterile 
cotton swab was taken and dipped into it and pressed firmly against the 
wall of the test tube so as to remove the excess broth from the swab.  
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Mueller Hinton agar plate were dried and swabbed in three 
directions to ensure complete distribution of the inoculums over the 
entire plate. The antimicrobial discs were dispensed on the Mueller 
Hinton agar plate using dispenser and pressed down to give complete 
contact with the surface of the agar.  
The discs were distributed evenly on the plate and the distance 
should not be closer than 24mm from centre to centre not more than 6 
discs were placed in a single plate 
[]
. After an incubation period of 16- 
18 hrs each plate was examined. The diameter of the zones which gave 
complete inhibition was measured. The diameter of zones of inhibition 
was interpreted according to CLSI standards for each organism.  
The following standard strains were used.  
 Staphylococcus aureus- ATCC 25923 
 Escherichia coli- ATCC 25922 
 Pseudomonas aeruginosa- ATCC 27823 
Panel of antibiotics included for testing antimicrobial sensitivity 
of Gram positive cocci. 
Antibiotics 
Disc 
Content 
Zone of Inhibition 
Sensitive Intermediate Resistance 
Penicillin 10 units ≥29 - ≤28 
Erythromycin 15µg ≥23 14-22 ≤13 
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Antibiotics 
Disc 
Content 
Zone of Inhibition 
Sensitive Intermediate Resistance 
Cefoxitin 30µg ≥22 - ≤21 
Ciprofloxacin 5µg ≥21 16-20 ≤15 
Co-trimoxozole 1.25/23.75µg ≥16 11-15 ≤10 
Amikacin 30µg ≥17 15-16 ≤14 
High level 
gentamicin 
120µg ≥10 7-9 ≤6 
Chloromphenicol 30µg ≥18 13-17 ≤12 
Stapylococcus aureus strains were screened for Methicillin 
resistance. 
DETECTION OF METHICILLIN RESISTANT 
STAPHYLOCOCCUS AUREUS: 
Cefoxitin Disc Method  
Colonies of Staphylococcus aureus(test isolate) were inoculated in 
peptone water and matched with 0.5 Mac Farland standard. The 
suspension was streaked onto cation adjusted Muller-Hinton agar plates. 
And Staphylococcus aureus ATCC 25923 (Control) was cultured onto 
another separate cation adjusted MHA. Cefoxitin disc (30 µg) were 
placed on the lawn culture of both the test and control isolates and 
incubated at 33-35ºC overnight. 
INTERPRETATION 
As per CLSIguidelines, 
Zone of inhibition: ≥22mm (mec A negative)  
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Zone of inhibition: ≤21mm (mec A positive)  
    Cefoxitin is used as a surrogate marker for mec A- mediated 
oxacillin resistance. Isolates that test as mec A positive should be 
reported as oxacillin (not cefoxitin) resistant.  
Minimum Inhibitory Concentration (MIC) was performed for 
MRSA isolates. 
The minimum inhibitory concentration is the least amount of 
antimicrobial that will inhibit visible growth of an organism after 
overnight incubation. 
Minimum Inhibitory Concentration (MIC)  for Detecting Vancomycin 
Resistance 
 Culture media:  cation adjusted Muller Hinton broth. (pH 7.2-7.4) 
 Preparation of stock antibiotic solution [83]: 
 Antibiotic stock antibiotic solution was prepared using the 
formula, 
1000 x V x C   = W  
P 
Where P = potency of the antibiotic in relation to the base.  
V = Volume of the stock solution to be prepared (10ml).  
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(For vancomycin, P = 950/1000mg; Himedia) 
C = Final concentration of the antibiotic solution (1024µg/ml) 
W = Weight of the antibiotic to be dissolved in the volume V.  
Preparation of Working Antibiotic Solution 
   10.77mg of vancomycin was weighed and dissolved in 10ml of 
distilled water. This solution was used as stock solution and stored  in a 
sterile screw capped container. 
Preparation of  Inoculum  for the Test and ATCC Control Isolates 
0.1ml of Mac Farland turbidity matched test organism and control 
was added to 9.9ml of separate MH broth and mixed well and stored in 
separate sterile screw capped containers. 
Procedure 
Thirteen sterile tubes were arranged in a rack. Using micropipette, 
1ml of peptone water was filled in all the test tubes. Doubling dilution 
of antibiotic (µg/ml) was prepared. 1ml of stock solution of the 
antibiotic was added to 1
st
 tube which would be 512 dilution. Then, 1ml 
was pipetted from the 1
st
tube and transferred to the second, 128 dilution 
and then serially diluted to subsequent tubes (64, 32, 16, 8, 4, 2, 1, 0.5, 
0.25, 0.125). 1ml was discarded from the last tube.  
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Finally 1ml of inoculum was added to all the thirteen tubes. The 
tubes were incubated at 35ºC for 18-24hrs. Similar procedure was 
followed for the control strain also. 
Observation 
The MIC of ATCC control strain was observed and since it was 
within sensitive range.  In the test isolates the lowest concentration of 
the antibiotic in there was no visible growth was taken as the MIC of the 
for the test isolate. 
Interpretation 
MIC of Vancomycin 
≤ 2µg/ml: Susceptible. 
4-8µg/ml: Intermediate. 
≥16µg/ml: Resistant 
Gram Negative Organisms 
The following preliminary and standard biochemical tests were 
performed; 
 Catalase, 
 Oxidase, 
 Motility, 
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 Methyl red, 
 Voges Proskauer, 
 Citrate utilization test, 
 Urease hydrolysis, 
 Hugh-Leifsons OF test, 
 Mannitol motility, 
 Lysine decarboxylase, 
 Ornithine decarboxylase, 
 Arginine dihydrolase. 
 Glucose, sucrose, lactose, maltose, mannose fermentation tests 
were also performed. 
 Antibiotic susceptibility tests were performed by Kirby Bauer’s 
disk diffusion method on Mueller- Hinton agar plate according to 
CLSI guidelines. 
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Panel of antibiotics included for testing antimicrobial sensitivity of 
Gram negative bacilli  
Antibiotics 
Disk content/ Gram 
negative bacilli 
Diameter of zone inhibition in mm 
Sensitive Intermediate Resistant 
Amikacin 30µg ≥17 15-17 ≤14 
Gentamicin 10µg ≥15 13-14 ≤12 
Ciprofloxacin 5µg ≥21 8-20 ≤17 
Cotrimoxozole 1.25/23.75µg ≥16 11-15 ≤10 
Cefotaxime 30µg Enterobacteriaceae ≥26 23-25 ≤22 
Acinetobacter sp. ≥23 15-22 ≤14 
Ceftazidime 30µg Enterobacteriaceae ≥21 18-20 ≤17 
P.aeruginosa 
Acinetobacter sp. 
≥18 15-17 
≤14 
 
 
Imipenem 
10µg 
 
Enterobacteriaceae ≥23 20-22 ≤19 
P.aeruginosa ≥19 16-18 ≤15 
Acinetobacter sp. ≥16 14-15 ≤13 
Piperacilin-
Tazobactum 
100/10µg ≥21 18-20 ≤17 
EXTENDED SPECTRUM ß-LACTAMASES (ESBL) 
DETECTION METHODS
[78][79][63][80][84]
:  
ESBL‟s are classified under Bush class A ß- lactamases which are 
capable of hydrolyzing penicillins – oxyiminocephalosporins and 
monobactams (Aztreonam) and inhibited by ß-lactamase inhibitors 
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(clavulanic acid, sulbactum and tazobactum) but have no detectable 
activity against cephamycins or carbapenems (Imipenem, Meropenem).  
ESBL SCREENING METHOD
[83]
:  
Isolates of gram negative bacilli showing the following resistance 
pattern were considered to be possible ESBL producing st rains. 
Antibiotic 
Zone diameter for possible ESBL 
producing strain 
Ceftazidime(30μg)  ≤22mm 
Cefotaxime(30μg)  ≤27mm 
Ceftriaxone(30μg)  ≤25mm 
Aztreonam(30μg)  ≤27mm 
1. Double Disk Diffusion Synergy Test:
[81]
  
In this test discs of third generation cephalosporins and 
Augmentin [Amoxicilin and Clavulanic acid] (20μg/10μg) (Himedia) 
were kept 30mm apart from centre to centre on a lawn culture of 0.5 
Mcfarlands test lsolate on Mueller Hinton agar (MHA) A clear extension 
of the edge of the inhibition zone of cephalosporin towards Augmentin 
disc was interpreted as positive for ESBL production.  
2.Phenotypic Confirmatory Double Disk Test: (PCDDT) 
[82] 
Antibiotics used: 
1) Ceftazidime (30µg) 
2) Ceftazidime/Clavulunic acid (30/10µg) 
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Detection of Extended spectrum beta lactamase production 
Using sterile loop five to six colonies of  similar morphology of 
the test organism were picked up and inoculated in peptone water and 
incubated at 37ºC for 2-4hrs and then the suspension was matched with 
0.5 Mac Farland standard (1.5x10
8
cfu/ml). Lawn culture was perfomed 
on MHA plate. Ceftazidime (30 µg), Ceftazidime/clavulanate (30/10 µg) 
disks were placed on the plate with 24mm gap between each disks and 
incubated at 37ºC overnight. 
Interpretation: (53) 
 A zone of   ≥ 5mm around the combination disks than the other 
counterpart disks is confirmed to be due to ESBL production.  
C-REACTIVE PROTEIN ESTIMATION (TURBILATEX 
METHOD) 
Clinical Significance 
The estimation of CRP was done by GenX CRP Turbilatex 
Quantitative method marketed by Proton Biologicals India Pvt. Ltd, 
Bangalore. 
PRINCIPLE OF THE METHOD 
The CRP-Turbilatex is a quantitative turbidimetric test for the 
measurement of C-reactive protein (CRP) in human serum or plasma. 
Latex particles coated with specific anti-human CRP are agglutinated 
when mixed with samples containing CRP. The agglutination cause an 
absorbance change, dependent upon the CRP content of the patient 
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sample that can be quantified by comparison from a calibrator of known 
CRP concentration. 
REAGENT 
Diluent(R1) Tris buffer 20 mmol/L, Ph 8.2. sodium azide 0.95 g/;  
Latex (R2) Latex particles coated with goat IgG anti-human 
CRP, 
Calibrator Ph 7.3. sodium azide 0.95 g/L 
Human serum. C-Reactive Protein concentration is 
stated on the vial label. 
PREPARATION 
Working reagent: Swirl the latex vial gently before use. Prepare 
the necessary amount as follows. 
1 ml Latex Reagent +9 ml Diluent 
PROCEDURE:  
Calibrate into test tubes labelled Calibrator(C) and Test(T).  
Reagent (Calibrator) (Test Sample) 
Working Reagent 0.5 mL 0.5 mL 
CRP Calibrator(Conc. 44 mg/L) 5 Μl - 
Sample - 5 μL 
1) Bring the working reagents and the photometer  to 37° C.  
2) Assay conditions : 
a. Wavelength: 540 nm (530-550nm) 
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b. Temperature : 37° C 
c. Cuvette light path : 1cm 
3) Adjust the instrument to zero with distilled water. 
4) Pipette into a cuvette. 
5) Mix and read the absorbance  
a. Initial absorbance A1- exactly after 60sec. 
b. Final absorbance A2- exactly 60 sec. after A1 
CALCULATIONS 
 
The reading is done by semiautoanalyzer.  
QUALITY CONTROL 
Control sera are recommended to monitor the performance of 
manual and automated assay procedures.  
REFERENCES VALUES 
Normal values up to 6 to 8 mg/L. 
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PROCALCITONIN ESTIMATION 
The measurement was done by QDx Instacheck PCT Kit 
manufactured by Biotech Med incorporated, Korea. 
PRINCIPLE 
The test uses a sandwich immune detection method, such that the 
detector antibody in buffer binds to PCT in serum sample and antigen –
antibody complexes are captured to another PCT antibody that has been 
immobilized on test strip as sample mixture migrates nitrocellulose 
matrix. Thus the more PCT antigen in serum, the more antigen-antibody 
complexes accumulated on the test strip. Signal intensity of fluorescence 
on detector antibody reflects the amount of antigen captured and is 
processed by QDx Instacheck 
TM
 Reader to show PCT concentration in 
specimen. The working range of QDx Instacheck 
TM
 PCT test is 0.25 ~ 
100ng/mL. 
DIAGNOSIS OF BACTERIAL INFECTION/SEPSIS 
PCT<0.5 Local bacterial infection is possible 
0.5<PCT<10 Infection is possible 
2<PCT<10 Infection(sepsis) is likely, unless other cause are known 
PCT>10 Severe bacterial sepsis or septic shock 
PROCEDURE 
1) 150μL of the serum or plasma sample was transferred using a 
pipette to the tube containing the detection buffer.  
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2) The lid of the detection buffer tube was closed and mixed the 
sample thoroughly with the detection buffer by shaking the tube 
about 10 times.  
3) 75μL of sample mixture  from the detection buffer tube was 
pipetted out and  dispensed it into the sample well on the test 
cartridge. 
4) For scanning the sample, loaded test cartridge was inserted into 
the test cartridge holder of the QDx Instacheck Reader.  
5) QDx Instacheck Reader  started scanning after 12mins  
6) The test result was displayed on the screen. 
INTERPRETATION OF TEST RESULT 
 QDx Instacheck Reader calculates the test result automatically 
and displays PCT concentration of the test sample in terms of 
ng/mL. 
 Working range of QDx Instacheck PCT is 0.25-100 ng/mL 
 Cut off of QDx Instacheck PCT is 0.5 ng/mL 
 Test result of more than 2ng/mL may reflect a severe sepsis.  
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QUALITY CONTROL 
 Control standards are not provided with QDx Instacheck PCT.  
 Internal control: QDx Instacheck PCT test has an inbuilt quality 
control indicator that satisfies the routine quality control 
requirements. This internal control test is performed automatically 
each time a clinical sample is tested.  
 An invalid result from the internal control  leads to display an 
error message on the QDx Instacheck Reader indicating that the 
test should be repeated. 
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RESULTS 
This cross sectional study was conducted in the Institute of 
Microbiology, Madras Medical College, Rajiv Gandhi Government 
General Hospital, Chennai in association with the department of 
Neonatology, at the Institute of Child Health, Egmore.  
Total number of 100 newborns with signs and symptoms of sepsis 
(who satisfied the inclusion criteria) were included in this study from 
october 2014 to August 2015. 
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TABLE-1: ANALYSIS OF SEX DISTRIBUTION IN 
NEONATAL SEPSIS CASES (N=100) 
Gender Number of cases(%) 
Male 45(45%) 
Female 55(55%) 
FIGURE-1: ANALYSIS OF SEX DISTRIBUTION IN 
NEONATAL SEPSIS CASES (N=100) 
 
Among 100 newborns, 45% were male babies and 55% were 
females babies. Females were predominantly affected groups than male.  
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FIGURE 2 : TIME OF CLINICAL PRESENTATION IN 28 
DAYS 
 
Majority (34%) of the babies affected during the first week (early 
neonatal period). Analyzing this data, overall females were most 
commonly affected in neonatal period. 
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TABLE 2:  DISTRIBUTION OF NEONATAL SEPSIS CASES 
ACCORDING TO THE ONSET (N=100) 
Onset 
Male Female 
Number(%) Number(%) 
Early Onset sepsis (EOS). (<72hrs) 5(33.3%) 10(66.7%) 
Late Onset Sepsis (LOS).(>72hrs) 40(47.1%) 45(52.9%) 
 It was found that 15% of babies had early onset sepsis and 85% 
of the babies had late onset sepsis. The incidence of late onset sepsis 
was higher than the early onset sepsis in the present study.  
TABLE 3:  WEIGHTWISE DISTRIBUTION OF NEONATAL 
SEPSIS CASES (N=100) 
Birth weight 
Male Female 
Number(%) Number (%) 
LBW 22(35%) 41(65%) 
Normal Weight 23(62.2%) 14(37.8%) 
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FIGURE 3: ANALYSIS OF WEIGHTWISE DISTRIBUTION 
OF NEONATAL SEPSIS CASES (N=100) 
 
Out of 100 cases studied for neonatal septicemia, 63% of the 
neonates were low birth weight (< 2.5 kg). Birth weight above 2.5kg 
accounted for 37% of neonatal septicemia.  It was found that low birth 
weight babies were more prone for neonatal sepsis.  
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TABLE 4: DISTRIBUTION OF CASES ACCORDING TO 
PERIOD OF GESTATION (N=100) 
Gender 
No of Term Cases 
(%) 
No of Preterm Cases 
(%) 
Male 32(54.2%) 13(31.7%) 
Female 27(45.8%) 28(68.3%) 
 
FIGURE-4: DISTRIBUTION OF CASES ACCORDING TO 
PERIOD OF GESTATION (N=100) 
 
Among Term cases (59), male babies (54.2%) were affected. 
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TABLE 5: RISK FACTORS ASSOCIATED WITH NEONATAL 
SEPSIS (N=100) 
Risk Factor Number of cases 
LBW 63(63%) 
PREMATURITY 41(41%) 
PROM 10(10%) 
MATERNAL FEVER 5(5%) 
VLBW 4(4%) 
BAD CRP 3(3%) 
HOME DELIVERY 2(2%) 
MECHANICAL VENTILATION 2(2%) 
CRP-Child Rearing Practices 
PROM-Premature Rupture of Membrane 
VLBW-Very Low Birth Weight 
FIGURE 5: RISK FACTORS ASSOCIATED WITH 
NEONATAL SEPSIS (N=100) 
 
The risk factors associated with an increased risk of neonatal 
sepsis among 100 cases, the commonest risk factor was low birth weight 
(63%) and prematurity (41%) 
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TABLE 6: CLINICAL FEATURES OF NEONATES WITH 
SEPTICEMIA (N=100) 
S. No Clinical Features Number (%) 
1 REFUSAL OF FEEDS  76(76%) 
2 RESPIRATORY DISTRESS 57(57%) 
3 FEVER 50(50%) 
4 LETHARGY  14(14%) 
5 ABDOMINAL DISTENSION  11(11%) 
6 INCESSANT CRY  10(10%) 
7 HYPOTHERMIA  9(9%) 
8 CONVULSION  8(8%) 
9 VOMITTING  7(7%) 
10 DIARRHOEA  3(3%) 
Out of 100 neonates, 77% of neonates had refusal of feeds. Many 
neonates had more than one symptom (36%). 
FIGURE-6:CLINICAL FEATURES OF NEONATES WITH 
SEPTICEMIA(N=100) 
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TABLE 7: MOST COMMON CLINICAL FEATURES IN 
SEPSIS 
ONSET REFUSAL OF FEEDS RESPIRATORY DISTRESS 
EOS(15) 11 13 
LOS(85) 65 44 
 
 
FIGURE 7: MOST COMMON CLINICAL FEATURES IN 
SEPSIS 
 
Among 15 cases of early onset sepsis, respiratory distress was the 
most common symptom. Among 85 cases of late  onset sepsis ,refusal of 
feeds was the most common symptom. 
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TABLE 8 :DISTRIBUTION OF CASES AMONG TWO 
CATEGORIES 
Categories No of Cases 
Proven Sepsis 24 
Suspected Sepsis 76 
Among 100 cases, 24%  was culture proven sepsis.  
 
FIGURE 8 :DISTRIBUTION OF CASES AMONG TWO 
CATEGORIES 
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TABLE-9: ANALYSIS OF BACTERIAL ISOLATES IN 
NEONATAL SEPSIS 
Organisms Frequency Percentage 
GNB 16 59.4 
GPC 8 40.6 
In neonatal sepsis, 59.4% of sepsis caused by gram negative 
organisms. 
 
FIGURE-9: ANALYSIS OF BACTERIAL ISOLATES IN 
NEONATAL SEPSIS 
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TABLE 10: ORGANISMS WISE DISTRIBUTION IN EOS AND 
LOS 
ORGANISMS EOS LOS 
Gram 
Negative(16) 
Klebsiella pneumoniae - 3 
Klebsiella 
pneumoniae(ESBL) 
1 2 
Acinetobacter baumannii 1 3 
Pseudomonas aeruginosa  - 3 
Escherichia coli  - 2 
Pseudomonas stutzeri - 1 
Gram Positive(8) 
Staphylococcus 
aureus(MSSA) 
- 3 
Staphylococcus 
aureus(MRSA) 
- 2 
Staphylococcus epidermidis - 2 
Enterococcus faecalis - 1 
Total 2(8.3%) 22(91.7%) 
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TABLE 11: DISTRIBUTION  OF ORGANISMS IN  
NEONATAL SEPSIS (N=24) 
Organisms Frequency Percentage 
Gram 
Negative(16) 
Klebsiella pneumoniae  6 25 
Acinetobacter baumannii 4 16.7 
Pseudomonas aeruginosa  3 12.5 
Escherichia coli  2 8.3 
Pseudomonas stutzeri 1 4.2 
Gram 
Positive(8) 
Staphylococcus aureus 5 20.8 
Staphylococcus epidermidis 2 8.3 
Enterococcus faecalis 1 4.2 
Total 24 100 
It was found that out of 100 samples processed, gram negative 
bacilli were isolated from 16(66.7%) blood samples. 
 Among gram negative bacilli, 37.5% were Klebsiella 
pneumoniae, 18.75% were Pseudomonas aeruginosa, 6.25% were 
Pseudomonas pstutzeri,25%  were Acinetobacter baumannii and 12.5% 
were Escherichia coli. 
Among gram positive bacilli, 62.5% were Staphylococcus aureus, 
25% were Staphylococcus epidermidis and 12.5% were Enterrococcus 
faecalis . Gram negative organisms were more common in neonatal 
septicaemia. Among gram negative organisms Klebsiella pneumoniae 
and among gram positive organisms Staphylococcus aureus were the 
most common isolates. 
 69 
FIGURE-10:  DISTRIBUTION  OF ORGANISMS IN  
NEONATAL SEPSIS (N=24) 
 
TABLE-12: ANTIMICROBIAL SUSCEPTIBILITY PATTERN 
FOR GRAM NEGATIVE ISOLATES IN NEONATAL SEPSIS 
CASES (N=16) 
Name of  
Antibiotics 
E coli  
(n=2) 
Klebsiella 
pneumoniae 
(n=6) 
Pseudomonas 
aeruginosa 
(n=3) 
Pseudomonas 
stutzeri (n=1) 
Acinetobacter 
baumanii 
(n=4) 
Sen % Sen % Sen % Sen % Sen % 
Amikacin(30μg) 2 100 5 83.3 3 100 1 100 2 50 
Gentamicin(10μg) 0 0 0 0 3 100 0 0 0 0 
Ceftazidime(30μg) 1 50 6 100 3 100 1 100 3 75 
Cefotaxime(30μg) 1 50 3 50 0 0 0 0 1 25 
Ciprofloxacin(5μg) 1 50 5 83.3 3 100 1 100 1 25 
Cotrimoxazole 
(1.25/23.75μg) 0 0 0 0 - - - - 0 0 
Piperacillin/  
tazobactum(100/10μg) 2 100 6 100 3 100 1 100 4 100 
Imipenem(10μg) 2 100 6 100 3 100 1 100 4 100 
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In the present study, Out of 100 cases of neonates, 24 were culture 
positive. Out of this, 16 were gram negative organisms. The GNB’s 
were 87.5% sensitive to amikacin , 81.25% showed sensitive to 
ceftazidime, 68.75% sensitive to fluroquinolones.  
 Pseudomonas aeruginosa isolates showed 100% sensitive to 
aminoglycosides , third generation cephalosporins. Acinetobacter 
baumanii was 50% sensitive to amikacin, 75% sensitive to ceftazadime. 
All GNB were 100% sensitive to imipenem, pipercillin- tazobactum. 
TABLE-13: TOTAL NUMBER OF ESBL PRODUCER IN 
NEONATAL SEPSIS 
Organism ESBL producer Non esbl 
Klebsiella Pneumoniae(6) 3(50%) 3(50%) 
There was no MBL, AMPC detected in the present study.  
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TABLE-14 : ANTIMICROBIAL SUSCEPTIBILITY PATTERN 
FOR GRAM POSITIVE ISOLATES IN NEONATAL SEPSIS 
CASES (N=8) 
NAME OF ANTIBIOTICS 
Staphlococcus  
aureus (n=5) 
Stapyhlococcus 
epidermidis (n=2) 
No % No % 
Amikacin(30μg) 5 100 2 100 
Gentamicin(10μg) 0 0 0 0 
Ciprofloxacin(5μg) 5 100 2 100 
Cotrimoxazole(1.25/23.75μg)  0 0 0 0 
Erythromycin(15μg) 0 0 0 0 
Penicillin(10units) 1 20 2 100 
Cefoxitin(30μg) 3 60 2 100 
Vancomycin (30μg) 5 100 2 100 
Out of seven Staphylococcus species, 5 isolates were Staph 
aureus and 2 isolates were Staphylococcus epidermidis. All 
Staphylococcus species showed 100% sensitive to vancomycin by 
minimum inhibitory concentration method(MIC). Staphylococcus aureus 
showed 60% sensitive to methicillin, 20 % were Methicillin resistant 
Staphylococcus aureus(MRSA). All gram positive cocci were 100% 
sensitive to fluroquinolones. Enterrococcus faecalis was isolated in one 
sample that was 100% sensitive to High level gentamycin(HLG).  
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TABLE-15  : INTERPRETATION OF MIC OF VANCOMYCIN 
FOR METHICILLIN RESISTANT STAPHYLOCOCCUS 
AUREUS BY MACROBROTH DILUTION METHOD 
Number of MRSA Isolates MIC value Interpretation 
2 ≤2μg/l Sensitive 
INTERPRETATION 
≤ 2μg/ml- Susceptible 
4-8 μg/ml- Intermediate 
≥ 16 μg/ml- Resistant 
TABLE-16: ANTIMICROBIAL SUSCEPTIBILITY PATTERN 
FOR ENTEROCOCCUS FAECALIS IN NEONATAL SEPSIS 
CASES (N=1) 
Name of Antibiotics 
Enterococcus faecalis (n=1) 
No % 
High Level Gentamicin (120μg) 1 100 
Ampicillin(10μg) 0 0 
Erythromycin(15μg) 0 0 
Penicillin(10μg) 0 0 
Vancomycin(30μg) 1 100 
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TABLE-17: SYSTEMIC INFECTIONS ASSOCIATED WITH 
NEONATAL SEPSIS (N=100) 
SYSTEMIC INFECTIONS NO. OF CASES(%) 
BRONCHO PNEUMONIA 14(14%) 
MENINGITIS 7(7%) 
NNH (DIRECT) 3(3%) 
NNEC 2(2%) 
SEPTIC ARTHRITIS 2(2%) 
SEPTIC ILEUS 1(1%) 
PYELONEPHRITIS 1(1%) 
    NNH= NEONATAL HYPERBILIRUBINEMIA. 
    NNEC=NEONATAL NECROTIZING ENTEROCOLITIS. 
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TABLE-18: SERUM PROCALCITONIN LEVEL IN 
NEONATAL SEPTICEMIA (N=100) 
Procalcitonin ng/ml Number(%) 
Negative(< 0.25) 37(37%) 
0.25 to 0.5 4(4%) 
0.5 to 10 52(52%) 
>10 7(7%) 
Out of 100 neonates, serum Procalcitonin was elevated  in  63% of 
neonatal sepsis. Among 63 procalcitonin positive cases, Majority of 
cases seen between 0.5 to 10ng/ml. Procalcitonin level >10 ng/ml 
indicates severe bacterial sepsis. Less than 0.25ng/ml was considered as 
PCT negative. 
TABLE-19: PROCALCITONIN VS CRP ESTIMATION IN 
NEONATAL SEPTICEMIA (N=100) 
Acute Phase Reactants 
Positive 
Number Percentage 
Procalcitonin 63 63 
C-Reactive Protein 43 43 
Pearson chi Square 
test 
DF - 
1 
p- value = 
0.004 
Significant 
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TABLE-20: COMPARISON OF CRP AND PROCALCITONIN 
IN INFECTION CATEGORIES 
 CRP Positive PCT Positive 
Proven sepsis(24) 15 62.5% 21 87.5% 
Suspected sepsis(37) 20 54.05% 27 73% 
Clinical sepsis(39) 0 - 15 38.5% 
FIGURE-11: COMPARISON OF CRP AND PROCALCITONIN 
IN INFECTION CATEGORIES 
 
TABLE 19: STATISTICAL ANALYSIS OF PROCALCITONIN 
PCT 
Blood culture 
Total 
Positive Negative 
POSITIVE 21 42 63 
NEGATIVE 3 34 37 
Total 24 76 100 
Sensitivity=87.5% 
Specificity=44.7% 
Positive predictive value=33.33% 
Negative predictive value=91.8% 
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TABLE-20: STATISTICAL ANALYSIS OF C-REACTIVE 
PROTEIN 
CRP 
Blood culture 
Total 
Positive Negative 
POSITIVE 15 27 42 
NEGATIVE 9 49 58 
Total 24 76 100 
Sensitivity=62.5% 
Specificity=65.3% 
Positive predictive value=35.7% 
Negative predictive value=84.4% 
On comparison of serum CRP and Procalcitonin estimation which 
are indicators of septicemia it was observed that estimation of 
procalcitonin (63%) detected more cases of septicemia than CRP 
estimation (43%). 
The sensitivity of PCT in detecting sepsis was 87.5% , its 
specificity was 44.70%   , its positive predictive value was 33.33%   
,and its negative predictive value was 91.80% . The sensitivity of CRP 
in detecting sepsis was 62.5%   , its specificity was 65.3%, its positive 
predictive value was 35.7%, and its negative predictive value was 84.4% 
. 
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In present study, the total WBC was normal in 11 out of 24 
cultures with proven sepsis. In neonates with an elevated PCT level may 
help in the diagnosis of  septicemia . In the present study elevated PCT 
level were high in both proven and suspected sepsis. In the present 
study, PCT test detected 87.5% of neonatal sepsis cases than CRP 
62.5%. There was a significant correlation between the serum PCT level 
and type of sepsis (p value=0.004).. 
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DISCUSSION 
This study was conducted in the Institute of Microbiology, 
Madras Medical College, Rajiv Gandhi Government General Hospital 
(RGGGH), Chennai in association with Institute of Child Health,  
Neonatal unit, Egmore. 
According to clinical symptoms of sepsis, microbiologic and 
laboratory results(C Reactive Protein, white cell count, platelet count 
and blood culture), neonates classified into three groups.  
Among three groups, 24 neonates had proven sepsis , in  whom 15 
neonates had elevated CRP and 21 neonates had elevated PCT. Among 
37 neonates with suspected sepsis, 20 neonates had elevated CRP , 27 
neonates had elevated PCT. Among 39 neonates with clinical sepsis, 
elevated CRP not seen but 15 neonates had elevated PCT. The total 
WBC was elevated in 11 out of 24 culture proven sepsis.  
  In the present study elevated PCT level seen  in  both proven and 
suspected sepsis. This finding was comparable with that of the study 
which was conducted by Yodolla  Zaheephasia Et al
[85]
 and Monneret 
et al
[86][89]
. 
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In the present study, Among 100 cases of neonatal sepsis, females 
babies (55%) were predominant group when compared to males (45%). 
This was contrary to the study conducted by Roy et al., (2002)
 [67].
This 
predilection of higher frequency among females was attributed towards 
the presence of risk factors like low birth weight and   prematurity 
[93][95][97-99]
. 
In the present study, Low birth weight babies (63%) were the 
most common risk factors associated with neonatal sepsis.    This was 
similar to the study conducted by   Stoll et al.,(1996)
 [3]
, Belady et al., 
(1997)
 [64]
 and Kaftan et al., (1998)
 [65]
. The risk factor associated with 
bacterial sepsis and meningitis was low birth weight according to 
Fanaroff et al., (1998)
 [66]
. Reports from India show 50-60% of septic 
babies were premature babies and very low birth weight babies. This 
was documented by Bang et al., (2001)
 [2]
. According to Roy et al., 
(2002)
 [67]
 the most frequent neonatal risk factor was low birth weight  
affecting  63.8% of the neonates.  
In this present study, prematurity (41%) was the second most 
common risk factors  associated with neonatal sepsis. This was smilar to 
study conducted by Takkar et al., (1974)
[8]
 and Singh et al., (1994)
 [7]
 
,Khatua et al., (1986)
 [68]
.  
The increased incidence of septicemia among premature neonates 
was attributed to their poor immune response like low level of Ig G, 
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impaired cellular immunity and poor mucosal defence according to 
Schreiber et al (1992)
 [69]
. 
In the present study, among 59 term babies, Male babies  (54.2%) 
were commonly affected. Neonatal sepsis is predominant among term 
male infants. Term male infants have an approximately twofold higher 
incidence of sepsis than term females as stated by Washburn et al., 
(1969)
 [70]
.   This sex difference is less clear in preterm , low  birth 
weight (LBW) infants . A gene located on the X chromosome is 
involved with a function of the thymus or with the synthesis of 
immunoglobulins. The female has double X chromosomes and possess a 
greater resistance to infection as explained by Schlegal R J and 
Bellanli A J (1969)
 [71]
.  
In this present study premature rupture of membranes contributed 
to 10 % of cases of neonatal sepsis. This was similar to the study 
conducted by Shah et al (2006)
 [72]
 .  
In this present study Late onset sepsis was more common than 
Early onset sepsis. Late onset sepsis is either hospital-acquired or 
community acquired and neonates usually present with septicemia, 
pneumonia or meningitis 
[13]
. 
In the present study, Refusal of feeds (76%) was one of the 
important symptoms observed. This was in accordance with study 
conducted by Das et al., (1980)
 [73]
 and Shashikala et al., (2000)
 [74]
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were refusal of feeds (61%), respiratory distress (40%), convulsions 
(29%) and abdominal distension (23%). 50% of infected newborn 
infants have a temperature higher than 37.8  C [75]. Feeding intolerance 
and abdominal distension was 46%; lethargy and hypotonia was 37% as 
per the report of Fanaroff et al., (1998)
 [66]
.  
In the present study, Among 15 cases of newborns with Early 
Onset Sepsis, Respiratory distress was the most common presentation. 
Similar results were obtained in studies conducted by A.S.M Nowshad 
Uddin Ahmed et al
[76]
. The most frequent clinical presentations of 
patients with culture proven serious neonatal bacterial infections were 
respiratory distress (47%), lethargy (40%), fever (36%), poor feeding 
(27%). Respiratory distress was significantly more common in early 
than late onset sepsis. 
Among 100 cases of neonatal sepsis, 24 were culture proven 
sepsis, which were correlated significantly (P value=0.004).  Gram 
negative bacilli constituted the predominant isolate (66.7%) followed by 
the gram positive cocci (33.3%)  
The most common organisms among gram negative bacilli was 
Klebsiella pneumoniae(25%) followed by  Pseudomonas 
aeruginosa(12.5%), Pseudomonas pstutzeri(4.2), Acinetobacter 
baumannii(16.7) and  Escherichia coli(8.3%). 
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In the present study, among gram positive cocci, 20.8% were 
Staphylococcus aureus, 8.3% were Staphylococcus epidermidis and 
4.2% were Enterococcus faecalis .  
Gram negative organisms were more common in neonatal 
septicemia. . This was smiilar to the study conducted by Kurien Anil 
Kuruvilla et al (1998)
 [77]
. In this study,  E.coli and Klebsiella which 
were the most common organisms responsible for EOS and LOS 
respectively. Enterococcus faecalis was also found to be a major 
pathogens in both EOS and LOS. The study on neonatal  sepsis by 
Trotman H and Bell Y.(2006)
 [21]
 reported 63% of the isolates were 
gram negative. 
ANTMICROBIAL SUSCEPTIBLTY PATTERN:  
In the present study, Out of 24 culture positive isolates, 16 gram 
negative organisms were isolated. Among Gram negatve 
organisms,87.5% of isolates were sensitive to amikacin , 81.25% 
showed sensitive to ceftazidime, 68.75% sensitive to fluoroquinolones. 
     Pseudomonas aeruginosa isolates showed 100% sensitive to 
aminoglycosides and third generation cephalosporins. Acinetobacter 
baumannii was 50% sensitive to amikacin, 75% sensitive to 
ceftazadime. All GNB were 100% sensitive to imipenem, piperacillin- 
tazobactum.  
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Out of seven Staphylococcus species, 5 isolates were 
Staphylococcus aureus and 2 isolates were Staphylococcus epidermidis.  
Staphylococcus aureus showed 60% sensitive to methicillin, 20 % were 
Methicillin resistant staphylococcus aureus (MRSA). All 
Staphylococcus species showed 100% sensitivity to vancomycin by 
minimum inhibitory concentration method(MIC). All gram positive 
cocci were 100% sensitive to fluroquinolones.  
Enterococcus faecalis was isolated in one sample that was 
sensitive to High level gentamicin (HLG). 
In the present study, serum procalcitonin was measured by QDx 
Instacheck PCT Kit .Among 63 procalcitonin positive cases, 82.5% 
showed a serum PCT level in the 0.5 to 10ng/ml, 11.1% of cases showed 
a serum PCT more than 10ng/ml and 6.4% of cases showed a serum PCT 
level less than 0.5ng/ml. Serum Procalcitonin level >10 ng/ml indicates 
severe bacterial sepsis. Less than 0.25ng/ml was considered as PCT 
negative.  
This findings was similar to the study conducted by 
Sucilathangam G.et al, that the serum PCT level was measured by using 
a quantitative immuno-luminometry method and the Lumitest kit 
(BRAHMS Diagnostic, Berlin, Germany). In this assay, a PCT level of 
>0.5 ng/ml was considered as pathological. PCT levels of 0.5-2 ng/ml, 
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2-10 ng/ml and >10 ng/ml were considered as weakly positive, positive, 
and strongly positive, respectively 
[92] [94]
. 
In the present study, the sensitivity of PCT in detecting sepsis was 
87.5%, its specificity was 44.70%   , its positive predictive value was 
33.33% and its negative predictive value was 91.80%. This finding was 
comparable with that of the study which was conducted by Chiesa et al
 
[47]
 (1998)reported that the sensitivity of diagnosing sepsis in neonates 
by PCT during the first 48 hours of life as 85.7% ; the sensitivity of 
detecting late onset sepsis was 100%.  
Infants receiving antibiotic therapy within the previous 72 hrs of 
PCT tests could also show decreasing levels of PCT. From the study by 
Ugarte and colleagues (1998) at a cutoff value of 0.6 ngm / ml., PCT 
had a sensitivity of 67.6%, a specificity of 61.3%
[96]
. 
In this study, the estimation of serum C-Reactive Protein was 
done by GenX CRP Turbilatex Quantitative method. The sensitivity of 
CRP in detecting sepsis was 62.5% , its specificity was 65.3%, its 
positive predictive value was 35.7% and its negative predictive value 
was 84.4%. The correlation between serum PCT and CRP was  
compared .Higher proportion of the neonates with sepsis had raised PCT 
than those without sepsis. 
In the present study, sensitivity of serum procalcitonin  (87.5%) 
for detection of neonatal sepsis was higher than the sensitivity of CRP 
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(62.5%). In most of the culture positive cases, the other sepsis screening 
tests were negative , but the level of PCT was elevated. This was similar 
to Boo et al findings. These findings support the usefulness of PCT in 
establishing an early diagnosis of neonatal sepsis.  Carot et al
[11]
 in 
their study showed that procalcitonin is more sensitive than the  CRP in 
the diagnosis of septicemia, meningitis, urinary tract 
infections
[100][102][107]
.   
The present study confirmed the findings of other investigators 
that PCT was more sensitive than CRP in the detection of neonatal 
sepsis. In a recent study , Koksal et al
[31]
 concluded that serum  
procalcitonin level was superior to serum CRP level in terms of early 
diagnosis of neonatal sepsis, in detecting the severity of the illness and 
in evaluation of the response  to antibiotic treatment 
[97][108][88][101]
. 
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SUMMARY  
 100 cases of newborn who fulfilled the inclusion criteria were 
included in this study 
 Females were most commonly affected than males in neonatal 
sepsis .Among term infants, male babies were commonly affected.  
 Late onset sepsis (after 72 hours of life) was more common (85%) 
than early onset sepsis (15%). Majority of babies were affected 
during the early neonatal period.  
 In the present study, overall 60% of neonates born by normal 
delivery were also affected.  
 The main risk factors involved  in  neonatal sepsis were  low birth 
weight(63%) and prematurity(41%). 
 Refusal of feeds(76%) was the most common symptom of 
neonatal septicemia. 
 The prevalence of neonatal septicemia  according to the present 
study was 24%. 
 Out of 24 culture positive isolates, 16 (66.7%) were gram 
negative Bacilli and 8(33.3%) were gram positive organisms, 
which was correlated significantly (p value= 0.004).  
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 Klebsiella pneumoniae (25%) was the most common isolate in 
neonatal sepsis, followed by Staphylococcus aureus (20.8%), 
Acinetobacter baumannii(16.7%), Pseudomonas aeruginosa (12.5%). 
 All GNB’s were sensitive(100%)  to carbapenem. 
 Among of 8 gram positive cocci (Staphylococcus species), 6 
isolotes were methicillin sensitive (75%) and 2  were Methcillin 
resistant (25%).The two MRSA solates were found to be sensitive 
to Vancomycin by macrobroth dilution method.  
 In this study, one Enterococcus faecalis was isolated that was 
sensitive to high level gentamicin.  
 In the present study, Serum procalcitonin was elevated in 21 out 
of 24 culture proven sepsis. Serum C-Reactive protein was 
elevated in 15 out of 24 culture proven sepsis. The total WBC was 
elevated in 11 out of 24 cultures with proven sepsis. In neonates 
with an elevated PCT level may help in the diagnosis of 
septicemia. In the present study elevated PCT level were high in  
both proven and suspected sepsis.  
 The sensitivity of PCT in detecting sepsis was 87.5%, its 
specificity was 44.70%, its positive predictive value was 33.33% 
and its negative predictive value was 91.80%.  
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 The sensitivity of CRP in detecting sepsis was 62.5% , its 
specificity was 65.3%, its positive predictive value was 35.7% 
and its negative predictive value  
 Since the serum PCT levels were elevated in almost all the culture 
proven sepsis cases, PCT can be used as a good tool for the 
diagnosis of  neonatal sepsis and  for treating the sepsis cases . 
 PCT was highly specific for bacterial infections (endotoxins 
released from the bacterial cell wall) and it helps differentiating  
it from viral infection. 
 It correlates well with the progression and the severity of the  
infection. 
 Evaluation of PCT levels helps in an  early diagnosis of the sepsis 
on the day of admission itself, before the blood culture is ready  
(usually after 3days of sampling). PCT helps in avoiding 
unnecessary, increased antibiotic usage where it is not required 
and thereby reducing the cost and the occurrence of bacterial 
resistance. PCT can also be employed for the prognosis of sepsis.  
 The findings of the present study  confirmed that the serum levels 
of  PCT was a reliable marker of sepsis than the serum levels of 
CRP and the WBC counts in the early diagnosis of neonatal sepsis 
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and in the evaluation of the response of the disease to the 
antibiotic therapy.  
 The benefits of measuring serum PCT helps in the  diagnosis of 
neonatal sepsis supports the acceptance of the test in the route 
practice. 
 In the present study, the mortality rate due to sepsis related causes 
was 5%. 
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CONCLUSION 
This study was conducted in the Institute of Microbiology, 
Madras Medical College, Rajiv Gandhi Government General Hospital 
(RGGGH), Chennai in association with Institute of Child Health, 
Neonatal unit, Egmore. The most common organisms was Klebsiella 
pneumoniae(25%) followed by Staphylococcus aureus(20.8%).  
In the present study, the sensitivity of the procalcitonin (87.5%) was 
higher than the sensitivity of CRP (62.5%) for the diagnosis of neonatal 
sepsis and also the early diagnosis of neonatal sepsis and antimicrobial 
therapy improve the outcome of the patients. Blood culture is a gold 
standard method to detect the organisms but the result is delayed( usually 
after 3days of sampling. Hence, initiation of immediate treatment is made 
possible by early detection of procalcitonin estimation. 
 The estimation of serum procalcitonin routinely in the diagnosis 
and follow up of neonatal sepsis, reduces the hospital cos t, avoiding 
unnecessary, increased antibiotic usage where it is not required and the 
occurrence of bacterial resistance. In conclusion,  the findings of the 
present study confirm that serum levels of PCT was a more reliable 
marker than the serum levels of CRP and WBC counts in  the early 
diagnosis of neonatal sepsis and in the evaluation of the response of the 
disease to the antibiotic therapy. 
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APPENDIX-I 
ABBREVIATIONS 
ATCC : American Type Culture Collections 
CLSI : Clinical and Laboratory Standards Institute  
CONS : Coagulase negative Staphylococcus. 
CRP : C-Reactive Protein 
DIC : Disseminated Intravascular Coagulation 
EOS : Early Onset Sepsis 
ESBL : Extended spectrum beta-lactamase 
GNB : Gram negative Bacilli 
GPC : Gram positive Cocci 
LOS : Late Onset sepsis 
MIC : Minimum Inhibitory Concentration 
MRSA : Methicillin-resistant Staphylococcus aureus  
MSSA : Methicillin-susceptible Staphylococcus aureus  
NICU : Neonatal intensive care unit 
PCT : Procalcitonin 
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FIGURE 5 :BIOCHEMICAL REACTIONS OF ENTERROCOCCUS FAECALIS 
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 APPENDIX II 
A. STAINS AND REAGENTS  
1. Gram staining 
 Methyl violet (2%)  
 
Grams Iodine  
Acetone  
Carbol fuchsin 1%  
l0g Methyl violet in 100ml absolute 
alcohol in 1 litre of distilled water 
(primary stain)  
l0g Iodine in 20g KI (fixative)  
Decolourising agent  
Secondary stain.  
B. MEDIA USED  
1. Mac Conkey agar  
Peptone  
Sodium taurocholate  
Distilled Water  
Agar  
2% neutral red in 50% ethanol  
10% lactose solution  
 
20g  
5 g  
1 ltr  
20 g  
3.5ml  
l00ml  
Dissolve peptone and taurocholate in water by heating. Add agar and dissolve 
it in steamer. Adjust pH to 7.5. Add lactose and neutral red shake well and mix.Heat 
in free steam (100°C) for 1 hour, then autoclave at 115°C for 15 minutes.  
2. Nutrient agar  
Peptic digest of 
 
5g  
animal tissue  
Sodium chloride  5g  
Beef extract  1.5g  
Yeast extract  1.5g  
Agar  15gm  
Final pH 7.4±0.2  
Suspend 28 grams in 1000 ml distilled water. Heat to boiling to dissolve the medium 
completely and sterilized by autoclaving at 15 lbs pressure (120°C) for 15 minutes.  
3. Blood agar (5% sheep blood agar)  
Peptone  
 
l0g  
NaCl  5g  
Distilled water  1 Ltr  
Agar  l0g  
Dissolve ingredients in distilled water by boiling, and add 5% sheep blood(sterile) at 
55°C adjust pH to 7.4.  
4. Chocolate agar 
 Sterile defibrinated blood  
 
10 ml  
Nutrient Agar (melted)  100 ml  
When the temperature was about 75°C, sterile blood was added with constant 
agitation. After addition of blood, kept in water bath and heating was continued till the 
blood changed to chocolate colour. Cooled to about 50° C and poured about 15ml into 
petri dishes with sterile precaution. 
5. Cation adjusted Mueller- Hinton Agar  
Beef infusion    300ml  
Caesein hydrolysate   17.5g  
Starch     1.5g  
Agar      l0g  
Distilled water    lltr  
pH = 7.4  
Sterilise by autoclaving at 121°C for 20 minutes 
C. MEDIA REQUIRED FOR BIOCHEMICAL IDENTIFICATION  
1. Oxidase Reagent  
Tetra methyl p-phenylene diamine dihyrochloride- 1% aqueous solution.  
2. Catalase  
3% hydrogen peroxide  
3.Coagulase test:-  
Human plasma was used for performing the coagulase test. This was obtained 
by centrifuging human blood, with added 0.1% EDTA, at 2000 rpm for 10 minutes.  
  A.Slide coagulase test:-  
One or two staphylococcal colonies were emulsified in a drop of saline on a 
clean microscopic slide. If the strain was not autoagglutinable, 
then undiluted plasma was added to the suspension using a Pasteur pipette. The 
appearance of coarse clumping visible to the naked eye within 5-10 seconds was taken 
as positive. Positive and negative controls were put up, to check the proper reactivity 
of plasma. Absence of clumping or any reaction taking more than 10 secondss were 
taken as negative slide coagulase test.  
B.Tube coagulase test:-  
1 in 6 dilution of the plasma was prepared in normal saline (0.85% NaCl) and 1 
ml volume of it was distributed in small tubes. One - two staphylococcal colonies 
were inoculated and emulsified in the diluted plasma. Positive control and negative 
control was put up using Staphylococcus aureus ATCC 25923 and Staphylococcus 
epidermidis respectively. To rule out spontaneous clotting of plasma, a tube of 
uninoculated plasma was taken. The tubes were incubated at 37°C for upto 4 hours 
and were observed at 1 hour, 2 hours and 4 hours by tilting the tubes through 90°. The 
tubes which showed any degree of clot formation were taken as positive. The tubes in 
which the plasma remained wholly liquid or showed flocculent or ropy precipitate 
were read as negative. The negative tubes were left at room temperature overnight and 
re-examined in the next day. 
4. Indole test  
Kovac's reagent  
Amyl or isoamyl alcohol 150ml Para dimethyl amino benzaldehyde lOg 
Concentrated hydrochloric acid 50ml  
Dissolve the aldehyde in the alcohol and slowly add the acid. Prepare in small 
quantities and store in the refrigerator. Shake gently before use.  
5.Christensen's Urease test medium 
Peptone  lg  
Sodium chloride  5g  
Dipotassium hydrogen phosphate  2g  
Phenol red  6ml  
Agar  20g  
Distilled water  1 ltr  
10% sterile solution of glucose  10ml  
Sterile 20% urea solution  100ml  
Sterilize the glucose and urea solutions by filtration. Prepare the basal medium 
without glucose and urea, adjust to pH 6.8-6.9 and sterilize by autoclaving in a flask at 
121°C for 30min. Cool to about 50°C, add the glucose & urea, and tube the medium 
as slopes.  
6. Simmon's Citrate Medium 
Koser's medium   1 ltr  
Agar     20 g  
Bromothymol blue   0.2% 40ml 
Dispense, autoclave at 121°C for 15 min and allow to set as slopes 
7. Triple Sugar Iron medium  
Beef extract    3g  
Yeast extract    3g  
Peptone    20g  
Glucose    lg  
Lactose    10 g  
Sucrose    l0g  
Ferric citrate    0.3g  
Sodium chloride   5g  
Sodium thiosulphate  0.3g  
Agar    12g  
Phenol red 0.2% solution  12ml  
Distilled water   1 ltr 
Heat to dissolve the solids, add the indicator solution, mix and tube. Sterilize at 
121°C for 15 min and cool to form slopes with deep butts.  
8. Glucose phosphate broth 
Peptone                 5g  
Dipotassium hydrogen phosphate     5g  
Water                1 ltr  
Glucose 10% solution    50ml 
Dissolve the peptone and phosphate and adjust the pH to 7.6. Filter dispense in 
5ml amounts and sterilize at 121°C for 15min. Sterilize the glucose solution by 
filtration and add 0.25ml to each tube.  
Methyl Red Reagent 
Methyl Red    l0mg  
Ethyl alcohol   30ml  
Distilled water   20ml 
Voges Proskauer Reagent  
Reagent A: Alpha naphthol   5g  
Ethyl alcohol     100ml  
Reagent B: Potassium hydroxide   40g  
Distilled water     100ml 
8. Peptone water fermentation test medium  
To the basal medium of peptone water, add sterilised sugars of 1% indicator 
bromothymol blue with Durham's tube. Basal medium peptone water Sugar solutions:  
Sugar     1ml  
Dislilled water   100ml  
pH = 7.6. 
9. Mannitol motility medium  
Agar     5g  
Peptone    lg  
Potassium nitrate   1g  
Mannitol    2g  
Phenol red indicator  
Distilled water 1000ml  
pH 7.2 
10. Phenolphthalein diphosphate agar  
 Sterilize a 1% aqueous solution of sodium phenolphthalein diphosphate by 
filtration and store at 4°C  
 Add 10ml of this solution to 1000ml melted nutrient agar cooled to 50°C and 
pour plates  
 Grow the staphylococcus overnight at 37°C on the medium  
 Invert the plate and pour a few drops of ammonia solution SG 0.88 into the lid  
 Read as positive a culture whose colonies turn bright pink within a few 
minutes. The colour soon fades.  
 
11. Potassium nitrate broth  
Potassium nitrate (KNO3)   0.2gm  
Peptone     5.0gm   
Distilled water    100ml 
The above ingredients were mixed and transferred into tubes in 5 ml amount 
and autoclaved.  
12. Phenyl alanine deaminase test  
Yeast Extract  3g  
Dl-Phenylalamine  2g  
Disodium hydrogen phosphate  lg  
Sodium Chloride  5g  
Agar  12g  
Distilled water  1 lr  
PH  7.4  
Distributed in tubes and sterilized by autoclaving at 121° C for 1 5 minutes, 
allowed to solidify as long slopes.  
13. Sugar fermentation medium  
Peptone   15g  
Andrade's indicator   10 ml  
Sugar to be tested   20g  
Water    1 litre 
Andrade's indicator is prepared from 0.5% aqueous acid fuchsin to which 
sufficient 1M sodium hydroxide has been added to turn the colour of the solution 
yellow.  
Dissolve the peptone and Andrade's indicator in 1 litre of water and add 20g of 
the sugar; sugars to be tested generally include glucose, sucrose, lactose and maltose. 
Distribute 3ml amounts in standard test tubes containing an inverted Durham tube. 
Sterilize by steaming at 100 degree C for 30 min on 3 consecutive days. 
 
                       
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ANNEXURE II 
PROFORMA 
 
 Name :                                                                       IP no: 
 Age:                                                                           Ward:      
 Sex: 
 Occupation: 
 Address: 
 Birth weight:   LBW/ Normal 
 Apgar Score: 
 Maturity: Preterm / Term / Post Term 
 Place of delivery : Tertiary care Hospital / Others 
 Blood grouping / Rh typing : 
 Duration of labour : 
 PROM 24 hrs: Less than 24 hrs / More than 
 Associated illness specify : Congenital anomalies if any 
 Immunization of  Mother with TT:  Yes / No 
 Antenatal period in Mother:Normal / Abnormal 
 H/O maternal fever during last Trimester / Labour : Yes / No 
 Previous Obstetrical History : 
 H / O Abortions : 
 Nature of Specimen : 
 Investigation required : 
 Date of collection of specimen: 
 Results declared : Blood culture/CRP/PCT 
 Organisms Isolated : 
 Hematological investigations: 
 TC 
 DC 
 Hb estimation 
 ESR 
 Peripheral smear study. 
Microbiological investigation: 
Sample collected: 
• Blood 
Direct examination: 
Gram’stain: 
Blood culture: 
 Inoculated intoBHI broth with subculture onto 
o MAC 
o BAP 
o CAP 
Isolate identified in blood sample: 
 
Antibacterial susceptibility pattern: 
 
 
 
 
 
ANNEXURE III 
CONSENT FORM 
STUDY TITLE:“Early diagnostic markers for neonatal sepsis: comparing 
procalcitonin and C-Reactive protein with the gold standard culture 
method ” 
I…………………………………………, hereby give consent to 
participate in the study conducted by Dr.R.Kesavan, Post graduate at Institute of 
Microbiology, Madras Medical College, Chennai and to use my personal 
clinical data and the result of investigations for the purpose of analysis and to 
study the nature of the disease, I also give consent to give my Baby’s Blood 
sample for further investigations. I also learn that there is no additional risk in 
this study. I also give my consent for my investigator to publish the data in any 
forum or journal  
  
   
 
Signature/ Thumb impression of the patient/ relative  Place:   
Patient Name & Address:      Date: 
 
 
 
Signature of the investigator:    Signature of the guide: 
 
 
INFORMATION SHEET 
TITLE 
“Early diagnostic markers for neonatal sepsis: comparing procalcitonin 
and C-Reactive protein with the gold standard culture method ” 
INVESTIGATOR:       Dr.R.Kesavan, 
                                        Post Graduate,  
                              Institute of Microbiology, 
                                       Madras Medical College, 
        Chennai - 600003. 
GUIDE:         Dr. S.Thasneem Banu, MD., 
                                      Professor of Microbiology, 
                                      Institute of Microbiology, 
                                      Madras Medical College, 
                                       Chennai 600 003. 
Early recognition and diagnosis of neonatal sepsis are difficult because of 
nonspecific clinical presentation.It is important to make an early diagnosis of 
neonatal sepsis for the prompt institution of antimicrobial therapy which 
improves outcome. 
 Although isolation of the causative microorganisms by using blood culture has 
been the golden standard method for its diagnosis, the result is ready only 24- 
72 hrs after the sampling and during this period, it is necessary to treat the 
suspicious infants for sepsis with antibiotics on the basis of the clinical 
symptoms and the risk factors. 
The present trend which is being applied for infants who are suspected to have 
neonatal sepsis may lead to unnecessary and increased antibiotic consumption, a 
higher incidence of the side effects due to their use, increased resistance to the 
antibiotics, a long hospitalization, the separation of the infants from their 
mothers and increased health costs. Therefore, using fast diagnostic methods 
including laboratory markers could be beneficial for the diagnosis of neonatal 
sepsis .  
I am doing to collect blood samples from clinically suspected cases of newborns  
are included in this study after getting informed consent only. This study is 
entirely voluntary and patient can withdraw any time from this study. Extra cost 
will not be incurred to the patients in this study. Any doubt regarding this study 
will be willingly clarified. Results of the study will be published. In case of any 
doubt please contact Dr. R.Kesavan, Cell: 9597194456 
 
Signature/ Thumb impression of the patient/ relative  Place:   
Patient Name & Address:      Date: 
 
 
 
Signature of the investigator:    Signature of the guide: 
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SNO NAME WEIGHT DAYS GENDER
REFUSAL OF 
FEEDS
FEVER LETHARGY
INCESSANT 
CRY
SEIZURES RD VOMITTING
LOOSE 
STOOLS
ABDOMINAL 
DISTENSION
RISK FACTOR DISEASE EOS/LOS XRAY CHANGES PRETERM 
NORMAL 
DELIVERY
1 B/O  DEEPA 10 M R F L BAD CRP LOS Y TERM LSCS
2 REKHA 4 F R I RD LOS Y TERM Y
3 GOMATHY 2.3 60HRS F R F PROM EOS NO TERM LSCS
4 INBANITHA 22 F R F L LOS NO TERM Y
5 LAKSHMI LAVANYA 2.2 60HRS F R L I RD V PROM EOS NO PT LSCS
6 VANITHA 20 M R F I PROM LOS NO TERM LSCS
7 GOWRI 10 M R F BAD CRP LOS NO TERM Y
8 SASIREKHA 13 M R F L PROM LOS NO TERM Y
9 JAYAKODI 28 F R L S MENINGITIS LOS NO PT Y
10 SUNITHA 2.2 1 F R L RD PROM /PIH EOS NO PT LSCS
11 BUVANESWARI MAGESH 1.9 1 F R I RD VLBW BRONCHO PNEUMONIA EOS Y PT Y
12 LINGESH 21 M R F V D MATERNAL FEVER SEPTIC ILEUS LOS Y PT LSCS
13 RADHIKA 6 F R LOS NO PT Y
14 SANTHOSH 19 M F I RD MECHANICAL VENTILATION LOS Y PT LSCS
15 VENNILA 1.8 1 F I RD HOME DELIVERY EOS NO PT Y
16 BAVANI 25 F R F I RD BRONCHO PNEUMONIA LOS NO PT LSCS
17 NANDINI 16 M R I RD BRONCHO PNEUMONIA LOS NO PT Y
18 SARASWATHI 20 F F I RD D LOS NO TERM LSCS
19 ESWARI 11 M R LOS NO TERM Y
20 JAYAPRIYA 21 F R F S PROM MENINGITIS LOS NO TERM LSCS
21 LALITHA MAGESWARI 7 M R F BRONCHO PNEUMONIA LOS Y TERM LSCS
22 AYYANAR 17 M R F L D BAD CRP MENINGITIS LOS NO TERM LSCS
23 ESTHER RANI 2.3 1 F R F RD V VLBW EOS NO TERM LSCS
24 JAYA MARY 15 F V D NNEC LOS Y PT LSCS
2 KATHIR 20 M R F S V PYELONEPHRITIS LOS NO TERM LSCS
26 RANI 4 F R F L LOS NO TERM LSCS
27 KALAIVANI 5 M R F D LOS NO TERM LSCS
28 USHA 5 F R F L BRONCHO PNEUMONIA LOS NO PT LSCS
29 PARAMESWARI 28 F R LOS NO PT Y
30 SURYA 28 M R I RD BRONCHO PNEUMONIA LOS Y TERM Y
31 SAVITHRI 15 F F L S MATERNAL FEVER MENINGITIS LOS NO PT LSCS
32 SANGEETHA 21 F F RD LOS NO TERM LSCS
33 MARUSELVI 12 M R F LOS NO TERM LSCS
34 KAVITHA 2 2 M F RD D HOME DELIVERY EOS NO PT Y
35 JAYANTHI 6 F R F PROM LOS NO PT LSCS
36 PARAMESWARI 20 F R RD LOS NO TERM Y
37 JAYANTHI 1.9 2 M R F RD LS VLBW EOS NO TERM Y
38 TEJAVATHI 5 M R F D MECHANICAL VENTILATION LOS Y PT LSCS
39 MOHAMAD SAMEER 5 M R RD LOS NO TERM LSCS
40 MADHURI LATHA 22 F R RD LOS Y TERM LSCS
41 GOWTHAM 28 M F RD MATERNAL FEVER LOS NO TERM Y
42 RANI 23 M R F L LOS NO PT LSCS
43 GUNASRI 25 F R RD V BRONCHO PNEUMONIA LOS NO TERM Y
44 VIGNESWARAN 23 M R RD LOS NO PT Y
45 SELVI 20 F R RD LOS NO TERM LSCS
46 LAKSHMI PRASANNA 2.6 1 M R RD PROM EOS NO TERM LSCS
47 KANAGA 28 M R F D MATERNAL FEVER LOS NO TERM Y
48 KOUSALYA 17 F F RD LOS NO TERM Y
49 VIGNESH 24 M R RD BRONCHO PNEUMONIA LOS Y TERM Y
50 DOWLINA 28 M R LS LOS NO TERM Y
51 VISWAJITH 27.000 M R RD BRONCHO PNEUMONIA LOS NO TERM Y
52 SANGEETHA 5 M R RD LOS NO TERM Y
53 RIYALAKSHMI 27 M F L S LOS NO TERM LSCS
54 DIWAKAR 22 M F L RD LOS Y TERM Y
55 PRIYA 22 F R RD LOS Y PT Y
56 JAYAPRIYA 12 F R RD LOS NO TERM Y
57 NAVANEEDHAM 9 M R LOS NO TERM LSCS
58 HEMANJINI 20 F F RD PROM BRONCHO PNEUMONIA LOS Y PT Y
59 DEEPA 24 F R F S MATERNAL FEVER MENINGITIS LOS NO TERM LSCS
60 SUREKHA 2.24 1 F R RD PROM EOS NO TERM Y
61 NIVEDHA 28 M R F SEPTIC ARTHRITIS LOS NO TERM Y
62 MUNUSAMY 21 M R F RD BRONCHO PNEUMONIA LOS Y TERM Y
63 KRISHNAVANI 28 F R F S MENINGITIS LOS NO TERM Y
64 CHITHRA 26 F R F SEPTIC ARTHRITIS LOS NO TERM LSCS
65 JEEVA 26 M R F L RD MENINGITIS LOS NO PT Y
66 ALLABAKESH 2.3 1 M R RD VLBW EOS NO PT Y
67 MEGALA 5 M F RD LOS NO TERM Y
68 MALLIGA 28 M F S RD LOS NO PT Y
69 ANITHA 20 F F RD D NNEC LOS NO TERM LSCS
70 POORNIMA 15 F F D LOS Y TERM Y
71 SUMITHRA 10 M R RD LOS NO TERM Y
72 RANJITHA 7 F F LS D LOS NO TERM Y
73 GEETHA 28 F R RD LOS Y PT Y
74 UMA 23 M R F LOS Y TERM Y
75 RAMA 20 M R F LOS Y TERM LSCS
76 KALAIVANI 1 F R RD LOS NO PT Y
77 PUNITHA 2 M R EOS NO PT Y
78 NAGAMMAL 4 F R F LOS Y PT Y
79 DIVYA 10 F R F LOS NO TERM LSCS
80 KAVITHA 4 F R F LOS Y PT Y
81 ANITHA 12 F R RD LOS Y PT Y
82 B/O SELVI 14 F R RD LOS NO PT Y
83 NANDHINI 20 F R F RD V LOS Y PT Y
84 BAWANI I 10 M RD LOS Y TERM Y
85 BHARATHI 28 F R RD LOS NO TERM LSCS
86 PREMALATHA 12 M R RD BRONCHOPNEUMONIA LOS Y TERM Y
87 INDUMATHY 8 F R RD LOS NO PT LSCS
88 THILAGAM 6 F R LOS NO TERM LSCS
89 SAROJINI 10 F RD LOS NO PT Y
90 KALAIVANI 1 F R RD BRONCHOPNEUMONIA EOS Y PT Y
91 SHAMEEMA 10 M R RD LOS NO PT Y
92 BHUVANESWARI 2 F RD EOS NO PT Y
93 HEMA 12 M R NNH LOS NO PT Y
94 KALAIVANI 5 F LOS NO PT Y
95 KALAISELVI 2 F RD EOS NO PT LSCS
96 PARVEEN 13 F RD LOS NO PT Y
97 SINDHAMANI 10 F R RD NNH LOS NO TERM LSCS
98 DIVYA 6 F R RD LOS NO TERM Y
99 KALAIVANI 4 M R RD NNH LOS NO TERM Y
100 POORNIMA DEVI 28 F F RD BRONCHOPNEUMONIA LOS NO TERM Y
NORMAL 
WEIGHT/
LBW
ALTERED 
HAEMOTOLOGICAL 
PARAMETERS 
CRP 
QUANTITATIVE
CRP 
QUALITATIVE
PCT < 0.25 
NEGATIVE
PCT < 
0.5 
PCT 0.5 -
10
PCT 
>10
ORGANISM AK GM PEN ERY COTRI CTX CEFTAZIDIME CIP CEFOXITIN IMI PT VAN CHLORAMPHENICOL AMPI HLG
N Y 5.964 + 10.5 NG
LBW Y 1.621 + 1.14 NG
LBW NO 4.32 + 0.99 NG
N Y 5.6 + 0.65 NG
LBW NO 9.8 + 2.94 GNB -KLEBSIELLA PNEUMONIAE(ESBL) S R _ _ R R S S _ S S _ _ _
N NO 1.62 - NEG NG
N NO 1.91 - NEG NG
N Y 24.4 + 54 GNB PESUDOMONAS STUTZERI S R _ _ _ R S S _ S S _ _ _
LBW NO 5.86 - 5.3 NG
LBW NO 18.4 - 8.93 NG
LBW NO 4.23 - 0.3 NG
N NO 1.81 - NEG NG
LBW NO 0.28 - NEG NG
N NO 1.42 - 0.56 GNB- KLEBSIELLA PNEUMONIAE S R _ _ R S S S _ S S _ _ _
LBW NO 3.9 + NEG NG
LBW NO 5.43 - 6.35 NG
N NO 3.23 + NEG NG
LBW NO 4.72 - 0.85 NG
N NO 5.43 - 0.6 NG
LBW Y 20.3 + 4.03 GPC - STAPH AUREUS (MSSA) S R S R R _ _ S S _ _ S _ _
LBW Y 5.9 - 7.3  PSEUDOMONAS AERUGINOSA S S _ _ _ R S S _ S S _ _ _
N Y 32 + 6.3 NG
LBW NO 5.12 - 1.12 NG
LBW NO 4.72 - NEG GNB-KLEBSIELLA PNEUMONIAE(ESBL) S R _ _ R R S S _ S S _ _ _
LBW Y 8.9 + 2.96 GNB ACINETOBACTER BAUMANI S R _ _ R R S R _ S S _ _ _
LBW NO 14.86 - NEG NG
LBW NO 1.82 + 28.1 GNB- KLEBSIELLA PNEUMONIAE S R _ _ R S S S _ S S _ _ _
LBW NO 25.3 + NEG NG R R _ _ R _ _ _ _ _ _ _ _ _
LBW Y 8.245 - NEG GNB ESCHERICHIA COLI S R _ _ R S S S _ S S _ _ _
LBW NO 3.11 - NEG NG
N Y 1.89 - 3.27 GNB ACINETOBACTER BAUMANI R R _ _ R R R R _ S S _ _ _
LBW Y 11.4 + 5.11 GNB- KLEBSIELLA PNEUMONIAE R R _ _ R S S S _ S S _ _ _
LBW NO 10.2 - 0.26 NG
LBW Y 2.9 + 3.01 NG
N Y 53.8 + 0.8 NG
N Y 9.82 + 2.01 NG
LBW NO 17.2 + 1.7 NG
N Y 11.32 - 0.43 NG
LBW NO 4.9 + 13 NG
N NO 21.8 + 1.8 NG
N NO 11.18 - NEG NG
LBW Y 2.32 + 1.26 NG
N NO 8.22 - NEG NG
LBW NO 3.92 + 1.72 GPC - ENTEROCOCCUS FAECALIS _ _ R R _ _ _ _ _ _ _ S _ _ R S
LBW NO 11.7 + 19 GPC - STAPH AUREUS(MRSA) S R R R R _ _ S R _ _ S _ _
N Y 23.89 - NEG NG
N Y 1.92 - NEG NG
LBW Y 2.58 - NEG NG
N NO 3.024 - 0.67 NG
LBW NO 5.89 + 1.92 NG
N NO 4.724 - NEG NG
LBW NO 4.89 - NEG NG
N NO 3.94 + NEG NG
N Y 9.2 - 2.63 NG
LBW Y 4.928 + 3.01 NG
LBW NO 15.24 - 0.65 NG
LBW Y 5.432 + 5 GNB-KLEBSIELLA PNEUMONIAE(ESBL) S R _ _ _ R S R _ S S _ _ _
LBW NO 29.524 + 9.99 NG
N Y 22.4 + 9.9 GNB ESCHERICHIA COLI S R _ _ R R R R _ S S _ _ _
LBW NO 30.2 + 4.32 GNB ACINETOBACTER BAUMANI S R _ _ R S S S _ S S _ _ _
N Y 29.12 + 1.62 GPC- STAPH AUREUS(MSSA) S R R R R _ _ S S _ _ S _ _
N NO 11.245 + 11.3 GPC- STAPH AUREUS(MRSA) S R R R R _ _ S R _ _ S _ _
LBW NO 18.41 + 8.32 NG
N Y 18.12 + 0.58 NG
LBW Y 9.02 - 0.9 NG    
LBW Y 8.34 - 0.6 NG
N NO 4.824 + 0.85 NG
LBW NO 7.28 - NEG NG
N Y 4.32 + 3.02 GPC- STAPH AUREUS(MSSA) S R R R R _ _ S S _ _ S _ _
N NO 12.43 - NEG GNB ACINETOBACTER BAUMANI R R _ _ R R S R _ S S _ _ _
N NO 3.3 - NEG NG
N NO 4.92 - YES NG
LBW NO 4.47 _ NEG NG
N NO 9.2 + YES GPC-CONS S R S R R _ _ S _ _ _ _ _ _ _ _
N NO 7.3 - YES NG
LBW NO 8.34 + NEG NG
LBW NO 6.98 + YES NG
LBW NO 5.8 - YES NG
N NO 8.24 + YES NG
LBW NO 8.9 - YES 1.8 GPC-CONS S R S R R _ _ S _ _ _ _ _ _ _ _
LBW Y 20.01 + YES NG
LBW NO 5.8 - YES PSEUDOMONAS AERUGINOSA S S _ _ _ R S S _ S S _ _ _
LBW NO 14.01 - YES PSEUDOMONAS AERUGINOSA S S _ _ _ R S S _ S S _ _ _
LBW NO 10.94 + YES NG
LBW NO 9.124 - YES NG
LBW NO 3.2 _ NEG NG
LBW NO 4.92 _ NEG NG
N NO 2.23 - NEG NG
LBW NO 5.9 - NEG NG
LBW NO 2.8 + NEG NG
LBW NO 4.74 - NEG NG
LBW Y 3.82 -  NEG NG
LBW NO 5.01 - NEG NG
LBW NO 8.8 - 0.65 NG
LBW NO 4.3 - NEG NG
LBW NO 1.014 - NEG NG
LBW NO 2.79 - NEG NG
LBW NO 3.82 - NEG NG
LBW NO 4.39 - NEG NG
N Y 10.4 - 0.85 NG
